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Abstract 
Pseudomonas aeruginosa is the major bacterial pathogen found in Cystic Fibrosis 
(CF) patients, with up to 80% being colonised by the age of 18. Within the CF 
lung, however, polymicrobial infections are increasingly common. In fact, the 
saprophytic fungi Aspergillus fumigatus is increasing observed in association with 
P. aeruginosa, which is correlated with poorer clinical outcomes.  The aim of 
this project was therefore to investigate whether the interaction between P. 
aeruginosa and A. fumigatus resulted in changes to its virulence potential using 
a range of in vitro and in vivo experimental methodologies.  
 
The series of experiments described herein investigated the effect that A. 
fumigatus biofilms had on the induction of a surrogate virulence factor elastase 
from P. aeruginosa through the use of a biochemical assay.  Elastase is produced 
by many strains of P. aeruginosa and causes host damage by cleaving elastin 
within the CF lung.  A. fumigatus biofilms were grown in a 24-well plate format 
and live and ethanol-killed biofilms of various stages of development were 
produced (8 h germlings, 12 h monolayer of proliferating mycelia, 24 h and 48 h 
mature biofilm). These were then exposed to planktonic wild type and clinical 
strains of P. aeruginosa.  Dead A. fumigatus biofilm was shown to increase 
elastase significantly in multiple strains, including a mucoid strain. It was also 
shown that the intact biofilm structure was essential to this increase in elastase, 
as disrupting the dead A. fumigatus biofilm and treating P. aeruginosa with the 
lysate did not result in a significant increase in elastase. Interestingly, the effect 
was restricted to dead biofilms, as presence of live A. fumigatus biofilm resulted 
in a significant decrease in elastase produced by certain P. aeruginosa strains.   
 
Despite a significant change in expressed elastase being found for P. aeruginosa 
type strain PA01 at the phenotypic level, a real time qPCR approach did not 
show any significant up-regulation of LasB, the gene encoding elastase, over 
multiple time points in response to dead 24 h A. fumigatus. The possibilities of 
transient gene expression or mRNA degradation with an increase in protein 
expression are potential explanations for this. 
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Cell culture studies utilising the A549 human lung epithelial cell line aimed to 
determine the effects of both supernatants from combinational cultures and 
elastase itself on a cell line of relevance to the CF lung.  Elastase was shown to 
detach A549 cells from the plastic surface they were grown on and adherent to 
using light microscopy, with no loss of viability as measured by alamarBlue.  The 
effect of combinational P. aeruginosa/A. fumigatus supernatants in contrast 
with their respective controls were difficult to determine due to the highly 
cytotoxic effect of live A. fumigatus in this project. 
 
A Galleria mellonella wax worm insect model was also utilised to test for 
synergy in P. aeruginosa/A. fumigatus co-infections.  This was performed by 
establishing the effect of an optimised P. aeruginosa inoculum on wax worm 
survival treated with dead A. fumigatus 8 h germlings. No significant difference 
were shown in the survival rates of this model when worms were injected with 
combinations of P. aeruginosa and killed A. fumigatus 8 hour germlings, though 
melanisation of the worms indicated an additive effect on the organisms.   
 
In conclusion, these studies demonstrated a relationship between A. fumigatus 
biofilms and an increased virulence expression from P. aeruginosa using a 
surrogate virulence marker, elastase.  Due to its known negative effects in 
regards to human health, this suggests that polymicrobial infections of both P. 
aeruginosa and A. fumigatus could generate increased morbidity in those 
susceptible to these infections.  Future work should be undertaken to unravel 
the exact mechanisms behind increased virulence expression in P. aeruginosa in 
response to A. fumigatus, and determine fully whether this is of important 
clinical significance and therefore a key bacterial/fungal interaction to focus on 
within CF studies. 
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Definitions 
 
3OC12HSL  3-oxo-C12-homoserine lactone 
A549   Human lung adenocarcinoma epithelial cell line 
ABPA   Allergic broncho-pulmonary aspergilliosis 
AIDS   Acquired immunodeficiency syndrome 
ANOVA   Analysis of variance 
ATP   Adenosine triphosphate 
ATTC   American type culture collection 
BHI   Brain Heart Infusion 
cDNA   Complimentary deoxyribonucleic acid 
CF   Cystic fibrosis 
CFTR   Cystic fibrosis transmembrane conductance regulator protein 
cfu   Colony forming unit 
Ct   Cycle threshold 
DNA   Deoxyribonucleic acid 
DMEM   Dulbecco’s modified Eagle’s media 
DMSO   Dimethylsulfoxide 
ECR   Elastin-Congo Red 
EDTA   Ethylenediaminetetraacetic acid 
FCS   Foetal calf serum 
h   Hour 
hip   High persistence mutants 
IgE   Immunoglobulin E 
IL   Interleukin 
kDa   Kilo Dalton 
LasB   Elastase structural gene 
LasI   Autoinducer synthesis protein LasI 
LasR   Transcriptional regulator LasR 
LB   Luria broth 
LDH   Lactate dehydrogenase 
M   Mucoid 
min   Minutes 
mm   Millimetre 
µg   Microgram 
µl   Microlitre 
mg   Milligram 
mRNA   Messenger ribonucleic acid 
MTT 3-(4,5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium 
Bromide 
N   Non-mucoid 
NAD   Nicotinamide adenine dinucleotide 
NDK   Nucleoside diphosphate kinase 
nm   Nanometer 
O.D.   Optical density 
PBS   Phosphate buffered saline 
PCR   Polymerase chain reaction 
PE   Pseudomonas Elastase 
proC   Pyrroline-5-carboxylate reductase 
qPCR   Real time PCR 
REDOX  Reduction-oxidation 
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RNA   Ribonucleic acid 
RNA-Seq  Whole Transcriptome Shotgun Sequencing 
rpm   Rotations per minute 
RPMI-1640  Roswell Park Memorial Institute-1640  
rpoD   RNA polymerase, sigma 70 (sigma D) factor 
SAB   Saboraud Dextrose Agar 
SEM   Scanning electron microscopy 
TE buffer  Tris-EDTA buffer 
Th2   T helper cell type 2 
Tris-HCl  Trizma hydrochloride 
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1 Introduction 
1.1. General Introduction 
Since Alexander Fleming discovered the antibiotic penicillin, a result of a 
serendipitous observation of a contaminated agar plate on which interactions 
between staphylococci and the then-unknown mould Penicillium spp. were 
observed, it has been evident that there are important consequences of such 
interactions (Ligon 2004).  Indeed, given the abundance of bacteria and fungi in 
the environment, which can infect humans, these interactions are probably 
common and therefore have potentially important implications for health.  
Despite this, research into the interactions between fungi and bacteria both in 
vitro and in vivo is scant.  We have yet to discover in full the consequences of 
these interactions, the mechanisms involved, and how they impact the host. 
 
1.2. Cystic Fibrosis 
With an incidence of 1 in 2500 of new-borns in the UK, Cystic Fibrosis (CF) is the 
most common lethal genetic disorder within the Caucasian population, affecting 
over 7000 people in the United Kingdom (Davies et al., 2007).  CF is a recessive 
autosomal genetic disorder which leads to abnormally viscous mucus within the 
respiratory system, generally resulting in early mortality due to an opportunistic 
infection of the respiratory tract.  These are caused by bacterial pathogens such 
as Pseudomonas aeruginosa and Staphylococcus aureus (Proesmans et al., 2008) 
and fungal pathogens such as Candida albicans and Aspergillus fumigatus (de 
Vrankrijker et al., 2011).   
 
In the 1950’s, this genetic disorder meant that death by 5 years of age was 
probable. Fortunately, since then diagnosis and treatment methods have 
improved, meaning the prognosis is considerably more optimistic today, with 
mean survival of 50 years and over being achieved (Dodge et al., 2007).  
However, early mortality and morbidity is still observed within CF patients so 
further progress is essential. In particular, studies into the impact of the 
bacteria and fungi which co-infect the CF respiratory tract is one area of 
particular interest.  As little data exists about how these interactions impact 
18 
upon the health of CF patients, novel treatment methods and understanding of 
the disease pathogenesis could be uncovered (Hogan. 2009). 
 
1.2.1. Genetic basis for CF 
CF is caused by a mutation in the gene on chromosome 7 which encodes for 
cystic fibrosis transmembrane conductance regulator (CFTR) protein (Bobadilla 
et al., 2002).  There are many different mutations of CFTR that can lead to CF, 
with in excess of 1500 mutations being implicated in the disease (O'Sullivan and 
Freedman 2009).  Although there is much work to be done in understanding a 
number of these, the functional alterations of some of the most common 
mutations have been detailed.  Five different classes have been described which 
correspond to the various functional alterations resulting from the gene 
mutation, as detailed in Table 1.1 (Proesmans et al., 2008; Treacy et al., 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
19 
Table 1.1. Mutation classes leading to CFTR protein dysfunction in Cystic Fibrosis patients. 
Adapted from Proesmans et al., 2008 and Treacy et al., 2011. 
 
Class Mutation Molecular consequence 
I Nonsense G542X 
Frameshift 394delTT 
Splice junction 1717-1GA 
No CFTR messenger ribonucleic acid 
resulting in no CFTR protein formed 
II Missense AA deletion ΔF508 Trafficking defect due to aberrantly 
folded protein which is degraded by 
the cell quality control mechanism, 
resulting in little to no CFTR protein 
present in the cell. 
III Missense G551D Full length CFTR protein is 
synthesised and incorporated into 
the cell membrane, but the 
regulation is defective leading to no 
function. 
IV Missense R117H Defective chloride conductance. 
V Missense A455E 
Alternative splicing 
3849+10kbCT 
Deregulation of transcription due to 
a splicing defect leads to a 
decreased amount of normal CFTR. 
VI Q1412X Unstable CFTR protein produced, 
causing an increase in ions other 
than chloride through the apical 
channels. 
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A class II mutation in which the phenylalanine at position 508 is deleted, 
accounts for around two thirds of the North American and North European CF 
population (O'Sullivan and Freedman 2009).  This results in a protein trafficking 
defect in which ubiquination of the protein occurs and CFTR protein is degraded 
by the endoplasmic reticulum or Golgi body (Farinha and Amaral 2005).   
The CFTR protein is expressed at the apical borders of epithelial cells in the 
exocrine glands throughout the body and has several important functions 
including an essential role in ion and fluid homeostasis (Riordan 2008).  CFTR 
acts predominantly as a chloride channel (Sheppard and Welsh 1999), but also 
has other regulatory roles such as ATP channel regulation, inhibition of calcium-
activated chloride channels and bicarbonate-chloride exchange. The most 
commonly accepted theory for why defects in CFTR result in disease is the “low 
volume” hypothesis (Treacy et al., 2011).  This states that the dysfunctional 
CFTR fails to prevent sodium absorption through the sodium epithelial channel 
leading to hyper-absorption of water, and a depletion of the surface airway 
liquid.  Due to this, the substantial mucus which is secreted into airways 
becomes more viscous as it becomes dehydrated and thus more difficult to clear 
from the respiratory tract. In effect, mucociliary cleaning of the respiratory 
tract becomes less effective.  This provides an environment in which 
opportunistic microbes can colonize the airways.  The presence of these 
pathogens within the ordinarily sterile lung leads to inflammation of the 
respiratory tract, which results in damage to the tissues of the lungs.   Over 
time, the function of the CF lung decreases due to this damage, correlating with 
disease progression in the patient (O'Sullivan and Freedman 2009). The most 
significant of the bacterial pathogens impacting upon CF patients is 
Pseudomonas aeruginosa. As such, this organism is of key interest to research 
into CF. 
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1.3. Pseudomonas aeruginosa and its role in cystic 
fibrosis 
P. aeruginosa is a ubiquitous Gram-negative rod-shaped bacterium which is 
found in soil, water supplies and the skin microflora, thus creating a high risk of 
exposure for CF sufferers.  P. aeruginosa has been found within water supplies in 
hospital environments, affecting showers, ice makers, flower vases and even 
within some medications such as eye drops (Kerr and Snelling 2009).  For 
example, in January 2012 three premature babies died of Pseudomonas infection 
in the Royal Jubilee Maternity Hospital in Belfast, whilst three others became 
infected (one dying from other causes, the other two recovering).  P. aeruginosa 
was also detected on the skin of five other babies who did not become infected  
(Wise 2012). Although it is of low virulence within an uncompromised 
population, P. aeruginosa is an opportunistic pathogen that can colonise various 
parts of the body such as the eyes, burn wounds or in the case of CF patients, 
the lungs (Lyczak et al., 2000).  In fact, P. aeruginosa ranks within the top five 
organisms responsible for pulmonary, bloodstream, urinary tract, surgery site 
and soft tissue infections within intensive care units (Trautmann et al., 2005).   
 
Hosts with a competent immune system effectively clear P. aeruginosa from the 
respiratory tract via mucociliary action and innate immune mechanisms (Sadikot 
et al., 2005).  However, immunocompromised hosts, such as AIDS patients, and 
those suffering from genetic disorders (CF), are at a distinct disadvantage in 
preventing airway colonisation by P. aeruginosa (Dropulic et al., 1995). 
 
Exposure of CF patients to P. aeruginosa is considerable, and by the age of 18 up 
to 80% of patients with CF will have been colonized by this organism, showing P. 
aeruginosa is a key pathogen for research within this area (San Gabriel et al., 
2004).   
 
 
 
22 
1.3.1. Pseudomonas biofilms in the CF lung 
In order to establish a chronic infection in the host, P. aeruginosa forms biofilms 
within the CF lung.  This was confirmed by the demonstration that the quorum 
sensing signals measured in CF sputum samples were consistent with that of 
biofilm bring present, as opposed to planktonic, cells.  Moreover, microscopy of 
the CF sputum revealed that Pseudomonas was present in biofilm-like structures 
(Singh et al., 2000).     
 
Biofilms are communities of microbes, be it one or multiple species, encased in 
an extracellular matrix composed of polysaccharide, proteins, glycolipids, 
extracellular DNA and cellular debris (Branda et al., 2005).  The matrix generally 
makes up 90% of the biofilm dry mass (Flemming et al., 2007).  In terms of 
human infection, including those within the CF lung, the species within these 
communities can include fungi and bacteria.  Biofilms are attached to a surface, 
generally in contact with some form of aqueous fluid.  They are complex three-
dimensional structures, containing water channels which allow necessary 
materials such as nutrients to be moved throughout the biofilm community.  
These structures are also variable and dependent on conditions, such as the 
availability of nutrients (Hall-Stoodley et al., 2004).  The process of biofilm 
formation is detailed in Figure 1.1. 
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Figure 1.1. Summary of the basic steps in bacterial biofilm formation. 
 1. Initial reversible attachment of planktonic microbes to a surface by weak interactions 
such as Van der Waal’s forces. 2. Irreversible attachment of microbes to the surface, 
associated with a phenotypic change in the organisms.  This single layer of microbes 
begins slime production, releasing the extracellular matrix.  3. This single slime layer 
begins vertical development, producing a more three dimensional structure.  4. The 
maturing biofilm, by which stage “towers” of biofilm are present containing water channels 
to facilitate nutrient acquisition by microbes within the inner layers.  5. The mature biofilm.  
At this stage, free-floating planktonic bacteria disperse from the biofilm and colonise other 
areas and initiate further biofilm formation (Watnick and Kolter 2000).  Taken from Dr. 
David G. Davies Lab, Birmingham University (http://www2.binghamton.edu/biology/ 
faculty/davies/research.htm) 
 
The mature P. aeruginosa biofilm can generally never be cleared from the CF 
lung.  The persistence of P. aeruginosa as a biofilm within the CF lung has been 
linked to multiple factors including a decreased production of antibacterial 
nitric oxide in CF patients (Chmiel and Davis 2003). Moreover, P. aeruginosa 
biofilms are mostly drug-resistant making treatment especially difficult 
(Drenkard, 2003).  The secretion of viscous mucus within the CF lung leads to a 
low oxygen environment which is thought to contribute to the growth of P. 
aerugnosa on top of the lung epithelial cells (Moreau-Marquis et al., 2008).   
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Upon initial infection by a P. aeruginosa clonal strain, the clone commonly 
persists for multiple years within the airway, diversifying due to mutations and 
the composition of its accessory genome.  Multiple clonal strains can co-colonise 
within the same host (Cramer et al., 2010).  Excessive inflammatory reaction 
initiated by the biofilm is likely to be connected to the hosts’ inability to 
eradicate the infection.  Therefore, host damage occurs, with IL-8 and 
leukotriene B4 production causing the recruitment of neutrophils, which release 
mediators such as neutrophil elastase (Radike et al., 2011).  Antibiotic 
treatment is largely unsuccessful even though the P. aeruginosa within the lungs 
are not necessarily antibiotic-resistant (El Solh and Alhajhusain 2009).   
 
Persister cells are known to occur within the P. aeruginosa populations within 
the CF lungs as high persistence (hip) mutants (Mulcahy et al., 2010).  It has 
been hypothesized that persister cells evade antibiotic treatment and allow 
drug-resistance mutants to develop and persist within the lungs (Horre et al., 
2010).  Persister cells are dormant variant cells which arise sporadically within 
microbial populations, such as the biofilm and are metabolically inert.  As 
antibiotics function on active targets, the dormant persister cells evade killing 
and can repopulate later.  These cells contribute heavily to relapse in those with 
biofilm infections, as shown in Figure 1.2 (Lewis 2010). 
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Figure 1.2. Both regular and persister cells form within the biofilm. 
Within a host, both regular cells and persister cells shed from the biofilm into the 
bloodstream, with antibiotics killing only the regular cells in the bloodstream and the 
immune system responsible for clearing the persister cells.  Antibiotic therapy also kills the 
regular cells within the biofilm, but the persister cells remain in their dormant state, 
protected by the matrix of the biofilm.  When the concentration of antibiotics drops, the 
persister cells in the biofilm become active again and repopulate the biofilm, leading to 
recurring infection (Lewis 2010). 
 
1.3.2. Pseudomonas aeruginosa virulence factors 
P. aeruginosa is associated with various virulence factors, and these include 
pseudomonad pyocyanin, rhamnolipid, alkaline protease, superoxide dismutase 
and elastase (pseudolysin), a key factor in pathogenicity (Mulcahy et al., 2010).  
The expression of these virulence factors varies over the course of infection due 
to microevolution, with the bacteria remaining virulent throughout the course of 
the CF patient’s life (Bragonzi et al., 2009). 
 
 
1.3.2.1. Elastase as a virulence factor 
Pseudomonas elastase (PE), also known as pseudolysin, is one of the most 
damage-inducing extracellular virulence factors acting on the host.  Secretion of 
this virulence factor has been detected in over 75% of P. aeruginosa clinical 
isolates (Kuang et al., 2011).   Encoded by the lasB gene, it is a 39.5-kDa zinc 
metalloproteinase which degrades the elastin present in the human lung, whilst 
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also acting on other matrix proteins such as lamanin and collagen types III and IV 
(Adekoya and Sylte 2009). It is a member of the thermolysin family (M4) of 
proteins, of which many members are virulence factors produced by pathogenic 
microorganisms including λ-Toxin from Clostridium perfringens (Adekoya and 
Sylte 2009). 
  
PE has been shown to be involved in the pathogenicity of pseudomonads in the 
host via three different mechanisms (Hoge R. 2010): (1) Direct tissue damage by 
PE leads to improved growth conditions for bacteria due to an increase in 
nutrient concentration, leading to an increased bacterial load which can 
contribute to further damage. (2) Further activity of PE can degrade various 
plasma proteins, including immunoglobulins, complement factors and cytokines. 
(3) There is also the possibility that an increased inflammatory response will 
occur due to the recruitment of neutrophils to the respiratory tract, producing a 
destructive inflammatory cycle (Kon et al., 1999; Schmidtchen et al., 2003). 
 
Therefore, the risk of continued infection is increased due to PE as it lowers the 
defence mechanisms of the lung and destroys important surfactant proteins. The 
inflammatory response can also be triggered by the presence of a biofilm, which 
PE also has a role in by activating nucleoside diphosphate kinase (NDK) within 
bacterial cells, an important enzyme which is key to cellular macromolecular 
synthesis and signalling and therefore has an important role in bacterial growth, 
signal transduction and pathogenicity (Chakrabarty 1998; Cathcart et al., 2011). 
 
Host cells are also capable of producing their own elastase.  Within the context 
of airway pathogenicity, neutrophil elastase is the most significant form of the 
enzyme, being found at substantial concentrations in the surface airway fluids of 
those suffering from airway diseases (Fischer and Voynow 2002).  With elastase 
being produced by some host cells themselves and by multiple pathogens within 
the CF lung, the chances of significant damage being caused is increased. 
 
Elastase has been implicated in causing chronic ulcers due to the degradation of 
host skin proteins and wound fluids (Schmidtchen et al., 2003), as well as 
causing corneal liquidation (Willcox 2007).  The presence of elastase in the lung 
has been shown to lead to structural damage by degrading basal membranes and 
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the tight junctions of epithelia.  For example the presence of desmosine, a by-
product of elastin breakdown in the lungs that can be detected in the urine to 
indicate elastolytic activity against elastin, has been shown to be elevated in CF 
patients (Viglio et al., 2000). It has also been demonstrated in animal models 
that elastase-deficient strains are less virulent within the lungs, and that the 
host is also better able to clear the bacterial infection (Blackwood et al., 1983). 
Due to ease of colonisation by P. aeruginosa of CF patients, and therefore 
exposure of their lungs to elastase, this is of particular interest in CF studies. 
 
The scenario is complicated enough with a single species infection of the CF 
lung, but in reality the ecology of the CF lung has been shown to be 
polymicrobial, and the interactions between these different microorganisms can 
be hypothesised to lead to a dynamic change in the expression of virulence 
factors, and could possibly contribute further to the difficulty in eradicating the 
biofilm via synergy between species.  This is part of the rationale behind studies 
into bacterial-fungal interactions within disease. 
 
 
1.4. Aspergillus fumigatus and its role in cystic 
fibrosis 
In addition to bacterial pathogens, yeasts such as C. albicans (Latge 1999) and 
filamentous fungi such as A. fumigatus (Gomez et al., 2010) also colonise the CF 
respiratory tract.   
 
A. fumigatus is a saprophytic fungus, living on dead organic matter, with its 
natural environmental niche being within the soil.  A. fumigatus is ubiquitous 
due to a high yield of airborne spores which are released as conidia into the 
atmosphere, explaining the high rates of exposure in CF patients (de Vrankrijker 
et al., 2011).  It has been found that on average we inhale at least several 
hundred conidia each day with some estimates claiming that 1 to 100 colony 
forming units of A. fumigatus can be found for each cubic meter of indoor and 
outdoor air (Knutsen and Slavin 2011).  The conidia are small enough (2-3μm) to 
become located in the alveoli of the lung following inhalation.  A. fumigatus is 
the most prominent filamentous fungi which infect CF patients, with prevalence 
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rates ranging from 6% to 58% depending on the study (Burns et al., 1999).  Other 
species of Aspergillus are also associated with infection, including A. flavus and 
A. niger, but A. fumigatus is by far the most prominent species in human 
infection.     
 
A. fumigatus produces biofilms in a different way from P. aeruginosa and other 
bacterial and fungal species, as shown in Figure 1.3 (Ramage et al., 2011). 
 
 
 
Figure 1.3. Biofilm formation of Aspergillus fumigatus. 
Biofilm development begins with initial adhesion of a conidial spore to a surface (0 h), 
before germling formation (8 h), development of a monolayer of intertwined hyphae (12 h) 
and finally a mature 3D filamentous biofilm mass (approximately 200 µm) encased with an 
extracellular matrix (24 h).  Confocal laser scanning micrographs stained using FUN1 cell 
viability stain demonstrate the appearance of A. fumigatus within the biofilm at each 
respective stage of development.  Three key gene classes associated with biofilm 
(adhesins, drug efflux pump activity and extracellular matrix) are indicated with their 
optimum time of expression.  Taken from Ramage et al., 2011. 
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A. fumigatus is also capable of producing elastase.  This was shown to be related 
to the pathogenesis of the fungi via an animal model (Kothary et al., 1984).  In 
this model, 6 elastase-producing and 4 non-elastase producing strains were 
tested in immunocompromised mice.  It was found that the elastase positive 
strains caused death in all mice tested, with hyphal growth and alveoli necrosis 
occurring within the lungs.  The elastase negative strains did not lead to 
destruction of the alveoli, and few hyphae were found in the lung tissue.  This 
indicates that elastase production may be important to A. fumigatus 
colonisation and invasion as with P. aeruginosa. 
 
The most common disease caused by A. fumigatus in CF patients is allergic 
broncho-pulmonary aspergilliosis (ABPA) which affects 7-9% of CF patients 
(Knutsen and Slavin 2011).  Those suffering from asthma are also at particular 
risk, with 1-2% of asthmatics suffering from ABPA (Luzzaro et al., 2011).  ABPA 
develops due to T helper cell type 2 (Th2) hyper-sensitivity to A. fumigatus 
hyphae colonizing the respiratory tract.  It is characterized by pulmonary 
infiltrates, with the lungs becoming filled with fluid.  An A. fumigatus-specific 
immune response via IgE and IgG is noted along with an increase in IgE levels.  A. 
fumigatus is also associated with asthma, bronchitis and aspergilloma. 
 
One study by Burns et al. on 520 patients showed that there was an increase in 
detected levels of A. fumigatus and C. albicans after six months of inhaled 
tobramycin treatment being utilised against P. aeruginosa against a control 
group (Burns et al., 1999). It is still to be determined whether or not antibiotic 
therapy simply allows colonisation by fungi, or whether it changes the 
environment of the CF lung allowing for the existing fungi to grow more 
prominently.  It does raise questions as to whether treatments against bacteria 
within the CF lung could be beneficial for fungi, and vice versa. 
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1.5. Mixed Bacterial and Fungal Interactions in the 
CF Lung 
The presence of bacteria and fungi within the CF lung has been known about for 
some time, yet looking at the interactions between such organisms in order to 
determine whether this leads to an increase in pathogenicity has been somewhat 
neglected. These studies could also lead to the discovery of mechanisms that 
microbes use to compete in a polymicrobial environment, which could ultimately 
be exploited in order to find novel treatments. 
 
Polymicrobial infections have been shown to occur fairly often in patients.  For 
example, one Italian report based on data gathered from April 2007 over 
multiple diagnostic centres indicated that approximately 8.5% of bloodstream 
infections were polymicrobial (Frey-Klett et al., 2011).  Another clinical study of 
94 patients with CF with a median age of 28 by Bakare et al, in 2003 showed 
that A. fumigatus was present in 45.7% of sputum samples and of these samples 
64.2% were also detected to have P. aeruginosa co-infection.  Figure 1.4 shows a 
summary of reported co-infections of microbial species within the CF lung. 
 
It has also been shown that these types of infections are more likely to lead to a 
less favourable disease outcome.   Therefore, interactions between species such 
as A. fumigatus and P. aeruginosa are liable to occur within the context of CF 
and should be studied. 
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Figure 1.4. Venn Diagram of Microbial Co-Infections in the CF Lung. 
Reported co-infections of microbial species within the CF lung.  Co-infections do not 
necessarily correspond with direct interactions between the species.  A, Aspergillus spp.; 
AV, adenovirus; AX, A. xylosoxidans; BP, bacteriophage; C, Candida spp.; Ent, 
enterobacteria; IPV, influenza and/or parainfluenza virus; K, Klebsiella spp.; M, 
mycoplasma; MA, Mycobacterium abscessus; N, Neisseria spp.; OF, oropharyngeal flora; 
RSV, respiratory syncytial virus; SM, S. maltophilia. Numbers refer to references: 1, 
(Petersen et al., 1981); 2, (Lambiase et al., 2006); 3, (Wahab et al., 2004); 4, (Moore et 
al., 2005); 5, (Burns et al., 1998); 6, (Hoiby 1974); 7, (Lording et al., 2006); 8, (Santana et 
al., 2003); 9, (Alvarez et al., 2004); 10, (Anzaudo et al., 2005); 11, (Ojeniyi et al., 1991).  
Taken from (Harrison 2007). 
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1.6. Clinical relevance of bacterial fungal 
interactions 
The main reason for these studies is to discover the clinical relevance of such 
interactions, and to examine whether they impact upon patient health.  If it is 
discovered that patient health and mortality is negatively impacted by mixed 
infections, it could inform us on the best approach to take in patient treatment. 
 
Amin et al. in 2010 looked at patients with persistent A. fumigatus infections 
(defined as two or more sequential A. fumigatus sputum or bronchoalveolar 
lavage cultures within a year) via a retrospective study of 230 patients below 19 
years of age (Amin et al., 2010).  It was found that P. aeruginosa was more 
prominent in those infected with A. fumigatus, with 54.1% being co-infected 
compared to 44.1% in an A. fumigatus negative group.  Moreover, this 
combination of microbes correlated with decreased lung function.   
 
Investigations revealed that in a combined group of the chronically and 
intermittently colonized patients, 86.4% of C. albicans - colonized patients were 
co-colonized with P. aeruginosa, whereas P. aeruginosa was only present in 
31.1% of the control group who did not have a history of C. albicans colonization 
(Chotirmall et al., 2010).   Meanwhile, Azoulay et al. in 2006 found that in 
mechanically ventilated patients suffering from respiratory failure, airway 
infection by C. albicans increased the risk of subsequent infection by P. 
aeruginosa (Azoulay et al., 2006). 
 
Ultimately we still have some way to go in terms of clinical data regarding these 
interactions and CF, but as these studies amongst others have demonstrated, the 
impact of mixed interactions seems to be of substantial importance. 
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1.7. Physical Interactions between bacteria and 
fungi 
Physical interaction in which the bacteria and fungi come into direct contact 
with one another is a way in which they can influence each another’s behaviour.  
For the bacteria, there are multiple possible advantages from such a relationship 
with the fungi.  (1) The fungi can be utilised as a source of nutrients (e.g. fungal 
cell wall, fungi-secreted products) for the bacteria to scavenge from.  (2) 
Bacterial antagonism of fungi can be enhanced by facilitating the concentration 
of antifungal compounds released by bacteria in the area of fungal growth.  (3) 
The bacteria can use the movement of the fungi within the environment to assist 
their own growth into new niches.  (4) Assistance in bacterial-fungal synergy for 
the breakdown of complex substrates (Hogan. 2009). Figure 1.5, adapted from 
Frey-Klett et al. shows the various mechanisms by which physical interactions 
occur. 
 
 
 
 
Figure 1.5. Physical interactions between bacteria and fungi. 
(a) Planktonic interactions in which bacteria and fungi co-exist within an environment 
without a direct association. (b) Mixed biofilm in which bacteria and fungi both co-exist 
within the extracellular matrix, with the potential for physical interaction greatly increased. 
(c) Intra-hyphal colonization in which bacteria have infected and live within fungal hyphae 
(Frey-Klett et al., 2011). 
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Mowat and colleagues showed experimentally that P. aeruginosa cells adhere to 
the filamentous structure of A. fumigatus  or to the hyphae of C. albicans 
(Mowat et al., 2010).  For this, mature A. fumigatus biofilms were exposed to P. 
aeruginosa overnight.  The biomass of mature biofilms following this treatment 
was minimally affected (15.2% of the untreated control) by the presence of P. 
aeruginosa.  Scanning electron microscopy (SEM) showed type strain PA01 
adhering to the biofilm structure of A. fumigatus biofilm as both single cells and 
as micro colonies (Figure 1.6).  It was also demonstrated that PA01 had an 
inhibitory effect on the growth of A. fumigatus biofilm within co-culture.  For 
example, when A. fumigatus conidia were grown overnight with live P. 
aeruginosa cells, the resulting fungal biomass was 14.5% (p<0.001) in comparison 
with untreated controls.  However, when mature A. fumigatus biofilm was 
treated with live P. aeruginosa cells, the resulting fungal biomass after 
overnight incubation was not significantly affected, showing 84.8% (p>0.05) 
biomass in comparison with untreated control.  This effect on A. fumigatus 
biofilm formation was generally observed over 9 different strains of P. 
aeruginosa (Mowat et al., 2010). 
 
 
Figure 1.6. SEM evaluation of interaction between Pseudomonas aeruginosa PA01 and 
Aspergillus fumigatus Af293 biofilms. 
Bacterial cells were shown to adhere throughout the dense intertwined filamentous 
structure of A. fumigatus.  Scale bar represents 2 μm.  Arrows indicate examples of P. 
aeruginosa adhering to the Aspergillus hyphae. (Mowat et al., 2010) 
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In terms of competition between these organisms for resources within the host, 
this could be important in giving an advantage to bacteria over the fungi with 
bacteria exploiting the fungi for nutrients and by-products.  It is also a 
somewhat specific process.  For example, P. aeruginosa can adhere to C. 
albicans in the hyphae form and cause fungal killing, but it is not capable of 
doing this to the yeast form. Other bacterial species such as Burkholderia 
cenocepacia are also capable of this (Jarosz et al., 2011). 
 
 
1.8. Indirect interactions between bacteria and fungi 
Within environments such as the microbiota of the CF lung, competition between 
various species is mediated by cell-to-cell signalling, or quorum sensing.  
Quorum sensing is mediated by signalling molecules (e.g. acylated homoserine 
lactones from Gram-negative bacteria, processed oligo-peptides for Gram-
positive bacteria and farsenol for fungi) (Watnick and Kolter 2000), which 
regulate gene expression of genes associated with biofilm formation in response 
to fluctuations in cell-population density (Miller and Bassler 2001).  P. 
aeruginosa, for example, uses quorum sensing to control processes such as 
biofilm formation, swarming motility and cell aggregation (Erickson et al., 
2002).  Molecules associated with quorum sensing such as N-butyryl-L-
homoserine lactone (C4-HSL) and N-butyryl-L-homoserine lactone(C4-HSL) have 
been isolated from the sputum of CF patients (Singh et al., 2000).  P. aeruginosa 
utilises a quorum sensing system called the LasI/LasR-RhlI/RhlR virulence system 
(Figure 1.7). 
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Figure 1.7. Quorum sensing in Pseudomonas aeruginosa.  
LasI protein is responsible for producing the homoserine lactone signalling molecule N-(3-
oxododecanoyl)-homoserine lactone (represented here by triangles).  RhlI protein 
synthesizes N-(3-butryl)-homoserine lactone (represented here by pentagons).  When the 
Las-I dependent autoinducer signal molecules rise to a critical level, they are bound by the 
LasR proteins.  This triggers the binding of the LasR-autoinducer complex to virulence 
factor promoters (such as LasB, encoding elastase) and stimulates virulence transcription.  
Subsequently, the LasR-autoinducer complex also induces the transcription of rhlR, which 
activates a second quorum sensing circuit.  RhlR bound to the RhlI-directed autoinducer 
activates another subset of LasR activated virulence factors and several other target 
genes not encoded for by the Las system.  The oval represents a P. aeruginosa cell.  
(Miller and Bassler 2001) 
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The influence of quorum sensing on bacterial-fungal interactions can be shown 
from work done by the Ramage group in 2010.  The LasIR quorum sensing system 
was demonstrated to have a role in the inhibition of A. fumigatus biofilm 
formation.  Knockout mutants of PA01 were used for this purpose: PA01:ΔLasI, 
which was unable to produce homoserine lactones, and PA01:ΔLasR, which was 
able to synthesize homoserine lactones, but could not respond to them.  Direct 
co-culture of these mutants with A. fumigatus did not inhibit biofilm growth 
(58.3% and 52.6% respectively) to the same extent as wild-type PA01 (22.9%)  
(Mowat et al., 2010). 
 
These interactions can be both beneficial and detrimental to the microbes 
involved in them.  Bacteria or fungi can provide the other with compounds which 
enhance growth and survival, causing up regulation of virulence determinants, or 
they can negatively impact upon survival and cause virulence down regulation.   
 
 
1.9. Examples of bacterial-fungal interactions and 
their impact on virulence 
Although the overall field of bacterial fungal interactions is still in relative 
infancy, multiple studies have been done into various examples of such 
interactions and how they affect the virulence of the species involved. 
 
One example of virulence up regulation by bacteria in the presence of fungi is 
that of P. aeruginosa up regulating phenazine toxin production when in the 
presence of C. albicans (Gibson et al., 2009).  It was shown in further studies 
that LasR knockout mutants (able to produce homoserine lactones, but not 
respond to their presence) would produce high levels of phenazine when 
exposed to both C. albicans directly or to a C. albicans secreted molecule called 
farnesol (Cugini et al., 2010).   Phenazine is associated with antibiotic properties 
against fungi such as C. albicans (Morales et al., 2010).   This virulence factor is 
capable of causing damage to the host lung, so therefore increased expression 
within the respiratory tract would contribute to morbidity in CF patients. 
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It has also been demonstrated that bacterial peptidoglycan-like molecules called 
muramyl dipeptides have been detected in human serum which could explain the 
increased virulence of C. albicans in the presence of bacteria (Xu et al., 2008).  
These molecules are known to induce hyphae formation in C. albicans   
 
The stage at which bacteria and fungi infect the host temporally could be one 
factor influencing their interactions.  For example, whether invasive fungi enter 
an environment already colonized by bacteria or vice versa.  An investigation 
utilising an animal model (Neely et al., 1986) demonstrated that P. aeruginosa 
infection preceding C. albicans infection within burn wounds on mice lead to an 
increase in mortality within the mice (Peleg et al., 2010).  Mice treated with a 
sublethal inoculum of P. aeruginosa before being treated with a sublethal 
inoculum of C. albicans showed 60% mortality compared to 10% in those mice 
treated only with C. albicans.  It was also inferred from these experiments that 
the death was due to C. albicans.  The P. aeruginosa virulence factor LasB, or 
PE, was implicated in causing this up regulation of virulence.  Theoretically, if 
this was found to be the case with A. fumigatus as well as other bacteria, and 
these fungi infected the CF lung following P. aeruginosa, it could be 
hypothesised that an increased risk to the health of the CF lung could arise. 
 
Not all interactions between fungi and bacteria involve inhibition of the others 
growth and physiology. However, one example of this is P. aeruginosa promoting 
the survival of C. albicans by secreting the extracellular signalling molecule 3-
oxo-C12-homoserine lactone (3OC12HSL), which inhibits the hyphae growth of C. 
albicans (Leclair and Hogan 2010).  This prevents bacterial killing of C. albicans 
as P. aerugonisa requires it to be in the hyphal form for killing to occur.   This 
may also indirectly assist C. albicans survival in that its response involves 
utilising the Ras1-cAMP-controlled signalling pathway which induces oxidative 
stress resistance, giving C. albicans an increased resistance against the 
phagocytic cells of the immune system.  Due to the high presence of LasR 
mutant strains within the CF lung (Hoffman et al., 2009), this must be taken into 
consideration for CF bacterial fungal interactions. 
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In terms of further studies, the effects of fungi other than C. albicans on P. 
aeruginosa are of particular interest.  The influence of the prominent A. 
fumigatus on P. aeruginosa should be high priority. 
 
 
1.10. Conclusions 
Despite the progression of CF treatment being a cause for celebration, there is 
still much work to be done, to elucidate all the factors involved in CF.  The 
many interactions and consequences of bacterial and fungal interactions within 
the CF lung is one aspect that needs further investigation.  The data that already 
exists in this area both in vitro and in vivo certainly points in this direction, as 
the virulence of pathogenic species that impacts upon patient mortality are 
affected by these interactions.  This project investigates a hypothesis that co-
infection with P. aeruginosa and A. fumigatus will lead to an increase in 
virulence in P. aeruginosa due to interaction with A. fumigatus, and utilises 
multiple methods to test this theory. 
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1.11. Aims of Study 
The aims of the study were as follows: 
 
1. To determine how A. fumigatus and P. aeruginosa interact 
phenotypically. 
 
2. To evaluate the effect of the presence of A. fumigatus biofilm on the 
virulence of P. aeruginosa via a surrogate Pseudomonas virulence marker, 
elastase, at a biochemical and molecular level and how this in turn 
impacts upon a human lung epithelial cell line. 
 
3. To determine whether A. fumigatus confers an increase in pathogenicity 
on P. aeruginosa within a wax worm animal model. 
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2 Materials and Methods 
2.1. Growth and maintenance of bacterial species 
Two type strains (PA01 and PA14) and two clinical isolates from the same patient 
(PA 06.72747A [mucoid] and PA 06.72747C [non-mucoid]) were used throughout 
this study (University of Calgary Foothills Hospital). PA01 ΔLasI (unable to 
produce homoserine lactones) and PA01 ΔLasR (unable to respond to homoserine 
lactones) were also used as virulence controls (kind gift from Prof Paul Williams, 
University of Nottingham). Finally, Burkholderia cenocepacia K56-2 was used as 
a clinical CF comparator to P. aeruginosa.  
 
2.1.1.1. Growth and maintenance of bacterial strains 
The relevant bacterial strains (PA01, PA14, PAATTC27853, PA 06.72747A, PA 
06.72707B, PA 06.72747C and PA 06.72707A) were taken from beads (Pro-lab 
Diagnostics) kept in frozen stocks at -80⁰C and streaked out onto Luria Broth (LB 
[Sigma, Poole, UK]) plates before overnight incubation under static conditions at 
37⁰C.  Plates containing bacteria were stored at 4oC, and were maintained by 
sub-culturing the bacteria onto new LB plates on a weekly basis.  
 
2.1.1.2. Standardisation of bacteria 
Bacterial colonies were taken from LB plates using a plastic loop before 
inoculation into 10ml of LB media.  This was incubated overnight at 37⁰C in an 
orbital shaker (IKA®, KS4000i control, Germany) set to 150rpm.  Following this, 
the bacteria were centrifuged (MSE Centaur 1, UK) to pellet, before washing 
with sterile PBS.  The washed cells were then resuspended in 10ml of sterile PBS 
before being standardized to an optical density of 0.3 at 492nm using a 
spectrophotometer (Fisher Scientific, Colorimeter model 45, USA), which 
corresponds to 1x108 cells/ml. A 1:100 dilution was made into media in order to 
produce the desired standardised bacterial concentration of 1x106 cells/ml for 
experimental work. 
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2.1.1.3. Growth Curves for Pseudomonas species 
The six selected strains of P. aeruginosa were adjusted to 1x106 cells/ml in 
RPMI-1640 media and 200μl of each strain was placed into six wells of a flat-
bottomed 96-well plate.  The plate was placed in the plate reader (FLUOstar 
Omega, BMG Labtech, UK) and optical density readings were taken at 492nm 
every hour for 24 h, with shaking in between each reading to prevent the 
bacteria from adhering to the surface of the plate and creating a biofilm.  The 
results were standardized against a blank control containing sterile RPMI-1640 
media. 
 
2.1.2. Growth and maintenance of Aspergillus species 
2.1.2.1. Maintenance of Aspergillus  
All work was carried out within an MDH Class I fume hood in order to contain A. 
fumigatus spores within the same environment. One hundred microlitres of 
Af293 conidia were pipetted onto a Saboraud Dextrose Agar (SAB) plate and 
spread evenly across the surface using a cell spreader, wherein they were 
incubated for four days at 37⁰C under static conditions.  After four days, the 
surface of the plate was covered in an A. fumigatus lawn containing the fungal 
conidia. These conidia were then harvested as previously described (Rajendran 
et al., 2011).  
 
Briefly, phosphate buffered saline (PBS) and Tween-20 (0.25% Tween-20 to 
99.75% PBS) was used to resuspend conidia from the A. fumigatus lawns.  To do 
this, 5ml of PBS-Tween was pipetted onto the surface of the plate before gentle 
rotation to allow the PBS-Tween to move across the surface of the plate and 
gather conidia.  The conidia were then collected in a Falcon tube and then 
standardised to 1 x 108 spores/mL by spore counting using a Neubeuer 
haemocytometer.  Fresh conidia were harvested approximately every two 
weeks, or more frequently as required. 
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2.1.2.2. Preparation of Aspergillus fumigatus biofilms 
Live and dead A. fumigatus biofilms were required in order to determine their 
effect on P. aeruginosa.  In order to prepare these biofilms, Af293 conidia were 
standardized to 5x105 conidia/ml in RPMI-1640 before addition of 500μl of 
conidia to the wells of a 24-well plate (Corning Costar, UK).  The conidia were 
incubated under static conditions in a 37⁰C incubator (Labnet Vortempt 1550, 
UK) for 8, 12, 24 and 48 h. 
 
To prepare killed A. fumigatus biofilms, excess media was removed from the 
biofilm before washing once with 500μl of PBS.  The biofilm was then treated 
with 500μl of 70% ethanol and incubated at room temperature for 10 min.  
Following this, the ethanol was removed and the biofilm was washed with PBS 
(x3) in order to remove residual alcohol.  The biofilm was left to dry for 10 min 
before addition of bacterial culture. Live A. fumigatus biofilms were prepared 
similarly, but without any ethanol treatment.    
 
2.1.2.3.  Preparation of disrupted Aspergillus fumigatus biofilms 
Dead 24 h Af293 biofilms were prepared as detailed in 2.1.2.2.  The biofilms 
were then removed from the surface of the plate using a cell scraper.  Disrupted 
biofilm in RPMI-1640 media was then transferred to a 2ml Micro tube (Sarstedt, 
Germany), and 0.5mm glass beads (Soda Lime) (Biospec, USA) were added to the 
specified level before being placed in a bead beater (Mini-Beadbeater-1, 
Biospec, USA) for 3 x 30 s at 4800 oscillations/min.  The micro tubes were 
centrifuged for 2 min at 3000rpm in order to separate the disrupted biofilm from 
the glass beads. 
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2.2. Physical interactions on agar plates 
2.2.1. Indirect growth of P. aeruginosa in the presence of A. 
fumigatus 
In order to show how P. aeruginosa and A. fumigatus respond to the presence of 
one another when growing on solid media, RPMI-1640 agar was prepared by 
adding 1.5% Agar No. 2 (Bioconnections, UK) to RPMI-1640 powdered media and 
autoclaving.  P. aeruginosa was adjusted to 1x106 cfu/ml in RPMI-1640 media and 
a cotton swab was used to draw a straight line vertically across the plate.  A. 
fumigatus was adjusted to 5x105 conidia/ml in RPMI-1640 media and a cotton 
swab was used to draw a straight line horizontally across the plate.  These were 
left to dry for 10-15 min at room temperature before being placed in a 37⁰C 
incubator.  Interactions were recorded through digital photography after 24 h in 
order to visually demonstrate the phenotypic interactions between the two 
species. 
 
2.2.2. Filter discs and zones of inhibition 
Zones of inhibition are used to quantitatively demonstrate inhibition on solid 
media. 10µl of P. aeruginosa at 1x106 cfu/ml in PBS, or A. fumigatus at 5x105 
conidia/ml in PBS were used to impregnate sterilised filter discs before being 
incubated at 37⁰C for 24 h.  Following this, three discs were transferred to each 
RPMI-1640 plate containing the appropriate microbial lawn.  For A. fumigatus 
discs, this was 20µl of P. aeruginosa at 1x106 cells/ml spread across the surface.  
For P. aeruginosa, this was 20µl of A. fumigatus at 5x105 conidia/ml spread 
across the surface.  Following 24 and 48 h, zones of inhibition were measured as 
mm of inhibition around the filter discs, with a mean being taken of the three 
discs per plate. 
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2.3. Elastin-Congo Red Assay 
The Elastin-Congo Red (ECR) assay was used as a biochemical method of 
quantifying the phenotypic expression of the virulence factor elastase, which 
acted as a surrogate marker to quantify increased virulence, i.e., this allowed  
P. aeruginosa virulence expression in response to various conditions related to A. 
fumigatus to be measured and quantified. 
  
2.3.1. Collection of supernatants for use in the ECR assay 
In order to analyse the effect of A. fumigatus biofilms on P. aeruginosa and B. 
cenocepacia elastase production, the supernatants produced by these bacteria 
were collected. Bacteria were grown overnight in LB broth and then centrifuged 
at 3000rpm for 10 min in order to form a pellet.  The pellet was washed using 
PBS, then resuspended in PBS before adjusting the optical density to 0.3 at 
492nm, corresponding with 1x108 cells/ml.  Bacteria were then adjusted to 1x106 
in RPMI-1640 media.  500μl was added to wells of a 24-well flat bottomed plate, 
in which live and dead A. fumigatus biofilms had been prepared (see 2.1.2.2).  
Empty wells were used for a control without the influence of A. fumigatus.  The 
bacteria were incubated under static conditions at 37⁰C with the A. fumigatus 
for 24 h.  Live and dead A. fumigatus were also incubated with RPMI-1640 to 
control for residual endogenous elastase activity.  An RPMI-1640 negative control 
containing no bacteria was also included. Following this, the supernatants were 
collected using a 2ml syringe, and were filtered using a 0.45μm filter and stored 
in Eppendorf tubes at -80⁰C until they were thawed and used for the ECR assay.  
 
2.3.2. Elastin-Congo Red Assay Protocol 
This assay was adapted from methodologies described elsewhere (Pearson et al., 
1997; Caballero et al., 2001; Schaber et al., 2004) and optimised as described in 
the results section. Elastin Congo-Red powder (Sigma-Aldrich, UK) was dissolved 
in distilled water to produce a stock solution of ECR at 100mg/ml. This was then 
further diluted in 0.1mM Tris-HCl buffer (pH 8.0) to produce 20mg/ml ECR 
buffer. In a round-bottomed 96-well plate, 100μl of ECR buffer was added to 
each well (giving the optimized ECR concentration of 10mg/ml) along with 100μl 
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of microbial supernatant.  The 96-well plate was then incubated for 6 h in a 
37°C incubator and shaken at 250rpm. 
 
Following this, the samples were mixed via pipetting to resuspend ECR powder 
before the plates were centrifuged for 3 min at 500rpm using an ALC PK 120R 
refrigerated centrifuge in order to separate the insoluble ECR powder from the 
soluble red pigment associated with elastase activity.  In cases where this had 
not been sufficient for full pelleting of the ECR powder, the plates were 
centrifuged again as necessary. 100μl of supernatant was taken from each well 
and transferred into a corresponding empty well in another plate in order for 
absorbance readings to be carried out using the plate reader (FLUOstar Omega) 
at 492nm.  
 
2.3.3. Elastase Standard Curve 
For each experiment, an elastase standard curve was produced in order to 
translate the optical density readings into quantitative data, i.e. µg/ml elastase 
production.  This was achieved by adding 100µl of elastase (Sigma-Aldrich, UK) 
at a known concentration to 100µl of sterile RPMI-1640 media and then serially 
diluting two-fold across the plate giving a range of concentrations between 
64µg/ml and 0.125µg/ml (64, 32, 16, 8, 4, 2, 1, 0.5, 0.25, 0.125μg/ml). The 
assay was processed as described in 2.3.2 with ECR substrate.  
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2.4. Cell Culture 
A human alveolar cell line (A549) was grown as an adherent monolayer in a 
humid 5% CO2/ air atmosphere at 37oC. 
 
2.4.1. A549 Cells 
The A549 tumour-cell line was developed in 1972 by D.J. Giard who initiated the 
cell line from a human alveolar cell carcinoma of a 58-year old Caucasian male 
(Lieber et al., 1976).  These cells are human alveolar basal type-II epithelial 
cells (also known as great alveolar cells, or granular pneumocytes), making them 
of interest to CF studies in which the lung frequently becomes chronically 
infected with P. aeruginosa, A. fumigatus and other pathogens (Lyczak et al., 
2002). 
 
2.4.2. Growth and Maintenance of the A549 Cell Line 
The A549 cells were initially taken from frozen stocks kept in liquid nitrogen at -
196⁰C.  The cells were thawed rapidly in a 37⁰C water bath with gentle 
agitation.  They were then added slowly to 10ml of Dulbecco’s Modified Eagles 
Medium (DMEM) (Sigma D6429) which had been supplemented with 10% Foetal 
Calf Serum (FCS) containing 1g/L glucose and 2mM l-glutamine (DMEM/10%FCS) 
before transfer to a T75 Flask (Cell Star) in which the cells were cultured.  This 
was maintained in 95% humidity at 37⁰C and 5% CO2 until they reached a density 
of 2x106 cells/flask. 
 
At this stage the cells were removed from the surface of the flask by using the 
serine protease trypsin (Invitrogen, Paisley UK).  Firstly, the medium was 
removed from the adherent cells within the flask and then 10ml of Dulbecco’s 
PBS (pH 7.3-7.4) was used to wash the cell monolayer twice.  Following washing, 
5ml of Trypsin/EDTA (Gibco) was added to the flask.  The flask was then moved 
to the 37⁰C incubator and monitored frequently over 5-15 min until the cells had 
detached from the flask surface.  At this point, 15ml of RPMI-1640/10% FCS was 
added to inhibit the enzymatic action of trypsin before it could cause damage to 
the cell line.  The cells were then transferred to a 25ml universal tube and 
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centrifuged at 80g for 5 min in order to pellet the cells and separate them from 
most of the Trypsin/DMEM.  The supernatant was removed leaving less than 
0.5ml covering the pellet, and this was resuspended following the addition of 
1ml further of RPMI-1640/10%FCS.   
 
2.4.3. Trypan Blue 
Trypan blue is a dye that is used to distinguish whether cells are alive or dead 
upon staining.  Treated A549 cells were dyed using trypan blue and the number 
of dead cells within the field of cells under a microscope was counted.  This 
allowed the viability of the cells after treatment to be further verified, as an 
additional measure outside of the Alamar Blue assay. 
 
2.4.4. Cell Microscopy  
The cell count was then determined using a haemocytometer, viewed under 
light microscope.  In brief, 20µl of the cell culture was gently mixed with 10µl of 
trypan blue dye, with 10µl of this being placed under a cover slip on the 
haemocytometer.  The cells within the centre square were counted, with cells 
stained blue by the Trypan blue being disregarded. The cells were then counted 
using a haemocytometer and standardised to a concentration of between 2x105 
and 5x105 cells/ml for seeding a T75 flask. The cells were then monitored daily 
using inverted phase contrast microscopy.   
 
2.4.5. A549 Cell Stock Preparation 
In order to preserve stocks for future work and in case the flask of cell culture 
being maintained was lost due to high passage number, accidents or 
contamination, some cells were frozen down again.  These A549 cells were 
grown until they reached 80% confluence. At which point they were removed 
from the flasks by trypsinisation, as described above.  After inhibition of trypsin 
and centrifugation described above the cells were adjusted to a concentration of 
between 1x106 and 2x106 cells/ml in DMEM/10%FCS, and then mixed gradually 
with an equal volume of 2 parts dimethylsulfoxide (DMSO) to 7 parts DMEM to 1 
part FCS. 
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2.4.6. Alamar Blue Assay 
The Alamar Blue cell viability assay (Invitrogen, Paisley UK) is used to quantify 
cytotoxicity of various agents upon cell lines (O'Brien et al., 2000).  This assay 
utilises Alamar Blue reagent, a water-soluble dye which undergoes a colour 
change based on the metabolic activity of the cells being tested.  A REDOX 
(reduction-oxidation) reaction caused by growing cells reduces Alamar Blue dye 
causing a colour change from blue to pink which is measurable using a plate 
reader, with high reduction corresponding to low cytotoxicity and high oxidation 
corresponding to high cytotoxicity.   
 
2.4.6.1. Alamar Blue Protocol 
A549 cells were seeded into the wells of 24-well flat bottomed cell culture 
plates (Costar, UK) at 1ml of 1x105 cells/ml in RPMI-1640 and left overnight at 
37oC 5% CO2.  The following day, microscopy was used to determine that the 
cells had successfully adhered to and grown in the wells, before the media was 
removed and replaced with 500µl of fresh media, or 500µl of media combined 
with an agent being tested for cytotoxicity (e.g. bacterial and fungal 
supernatants). Each experimental condition was tested in triplicate wells on 
three separate occasions.  The plates were then returned to the incubator and 
left for approximately 24 h.  Following this, 50µl of media was removed from 
each well and replaced with 50µl of Alamar Blue reagent (giving a 1:10 ratio) 
and left to incubate for approximately 3 h.  Sterile media containing Alamar Blue 
reagent was used as a control.  100µl was removed from each well in triplicate, 
giving 9 replicates for each condition per experiment, and transferred to a 96-
well flat bottomed plate (Costar).  Absorbance readings were taken at both 
570nm and 600nm using the plate reader (FLUOstar Omega, BMG Labtech, UK). 
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2.4.6.2. Alamar Blue Percentage Reduction Analysis 
In order to calculate the percentage of reduction of Alamar Blue within the 
assay, the values recorded were inputted into an absorbance equation.  This 
equation is stated as: 
 
 
In which:   E = molar extinction coefficient 
 
O1 = E of oxidized Alamar Blue at 570nm  
O2 = E of oxidized Alamar blue at 600nm 
R1 = E of reduced alamar Blue at 570nm 
R2 = E of reduced alamar Blue at 600nm 
A1 = absorbance of test wells at 570nm 
A2 = absorbance of test wells at 600nm 
N1 = absorbance of negative control well at 570nm 
N2 = absorbance of negative control well at 600nm 
 
By utilising these calculations, the percentage reductions of Alamar Blue for 
each well were determined, allowing cytotoxicity to be measured. The RPMI-
1640 control well is taken as 100% percentage reduction of Alamar Blue for the 
purposes of these experiments, with the test wells being standardized against 
this. 
 
2.4.6.3. Photography of A549 Cells 
Light microscopy was carried out to visualize the effect of relevant treatments 
on A549 cells.  This was carried out at x25 magnification on a Leitz Labovert 
light microscope (Leitz, Wetzlar, Germany) and photographs were captured 
using a Canon IXUS 220HS digital camera (Canon, Japan). 
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2.5. Real Time PCR Analysis 
2.5.1. RNA Extraction, Quantification and cDNA Synthesis 
RNA was extracted from PA01 cells grown in both the presence and absence of 
dead Af293 biofilm at 1x108 cells/ml through the use of the RNeasy mini kit 
(Qiagen, UK) and RNAprotect Bacteria Reagent (Qiagen), according to 
manufacturer’s instructions.  The bacterial RNA was stabilised by adding 1 
volume to bacterial culture to 2 volumes of RNAprotect Bacteria Reagent.  The 
cells were lysed using lysozyme at 1mg/ml in TE buffer before collection of RNA 
and subsequent purification using the RNeasy mini kit. The RNA obtained was 
quantified using the NanoDrop 1000 Spectrophotometer (Thermo Scientific). 1.5 
µL of RNA from each sample was loaded onto NanoDrop pedestal. The resultant 
RNA was of high quality, approximating 2.0 (260/280). cDNA synthesis was 
achieved using high capacity RNA-to-cDNA synthesis kit (Invitrogen, Paisley UK).   
 
Reverse transcription (RT) reaction mix was prepared as detailed in Table 
2.1A.20 µl of RT reaction mix was aliquoted into reaction tubes which were 
sealed and briefly centrifuged to spin down contents and eliminate air bubbles.  
The tubes were kept on ice before being loaded into the thermal cycler.  The 
thermal cycler was programmed as detailed in Table 2.1B before the reverse 
transcription run was carried out.  cDNA was stored at -20⁰C before use. 
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Table 2.1. cDNA synthesis. A) Components of RT reaction mix (per 20 µl 
reaction). B) Reverse transcription cycle conditions. 
 
A) 
Component Volume/Reaction (µl) 
 +RT -RT 
2X RT Buffer 10.0 10.0 
20X RT Enzyme Mix 1.0 - 
Nuclease-free H20 Q.S. to 20 µl Q.S. to 20 µl 
Sample Up to 9 µl Up to 9 µl 
Total per Reaction 20.0 20.0 
 
B) 
 
 Step 1 Step 2 Step 3 
Temperature (⁰C) 37 95 4 
Time 60 min 5 min ∞ 
 
 
 
2.5.2. DNA digestion and RNA cleanup 
In order to prevent the presence of DNA contamination within RNA samples, a 
DNase digestion was carried out on each sample according to the manufacturer’s 
instructions (Qiagen).  DNase I (Qiagen) dissolved in RNase-free water was used 
for this.  ≤87.5 µl RNA, 10µl RDD and 2.5 µl DNase 1 stock solution were mixed 
and made up to 100µl with RNase-free water and incubated on the desktop for 
10 min at room temperature before RNA cleanup was carried out following the 
manufacturer’s instructions, resulting in RNA of higher integrity.  This was done 
by adjusting the sample to 100 µl with RNase-free water before adding 350 µl 
Buffer RLT and mixing.  250 µl ethanol (96%) was added to the diluted RNA and 
mixed well.  The sample was transferred to a RNeasy Mini spin column placed in 
a 2 ml collection tube.  This was then centrifuged for 15 s at 10,000 rpm.  The 
flow through was discarded.  500 µl Buffer RPE was added to the RNeasy spin 
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column.  This was then centrifuged for 15 s at 10,000 rpm to wash the spin 
column membrane.  This was then repeated with a further 500 µl Buffer RPE for 
2 min.  The RNeasy spin column was then placed in a new 1.5 ml collection tube.  
30 µl RNase-free water was added directly to the spin column before 
centrifugation at 10,000 rpm for 1 minute to elute the RNA.  The RNA was then 
collected and stored at -20⁰C. 
 
2.5.3. qPCR 
Expression levels of LasB were measured in relation to the housekeeping gene 
rpoD.  rpoD is a critical housekeeping gene which encodes a sigma factor, and 
has previously been shown to be a good internal control for qPCR experiments in 
P. aeruginosa (Savli et al., 2003).  The primers were taken from Lee and co-
workers (Lee et al., 2011) and the thermal profile described by Sang Sun Yoon 
via personal correspondence (Tables 2.2).  Each well contained 12.5 µL of SYBR 
green master mix (Invitrogen, UK), 0.5 µL of forward and 0.5 µL of reverse 
primers, 1 µL of cDNA and 10.5 µL of DNase/RNase free water (Qiagen, UK) to 
make up a total volume of 25 µL.  A final concentration of 200 nM per primer 
was utilised. 
 
The mean efficiencies were determined in the sample triplicates and used to 
adjust the cycle threshold (Ct) values. Ct values were used for the quantitative 
comparison of the amplification rates. After baseline subtraction, the mean Ct 
values of the triplicates were determined and transformed into relative 
quantities utilising an existing calculation formula set up in Excel (Livak and 
Schmittgen 2001).     
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Table 2.2. Primers used in this study. 
A) Primers were chosen in line with previous literature. B) Primer conditions; including 
temperature and number of cycles. 
 
A) 
Target  Primer Reference 
LasB Forward TTAGCACTCCTTGGCAAAAC  
(Lee et al., 2011) 
 
LasB Reverse CAGAGACAGCAGAGCACACAA 
rpoD Forward CAAGGCTGAGAACGGGAAG  
(McKimmie et al., 2008) rpoD Reverse GGTGGTGAAGACGCCAGT 
 
 
B) 
Function Temperature 
(ºC) 
Time Cycles Reference 
Denaturation 55 2 min 1 Personal 
correspondence 
with Sang Sun 
Yoon, Yonsei 
University 
College of 
Medicine 
Denaturation 
Annealing 
Extension 
95 
60 
59 
10 min 
30 s 
1 min 
 
40 
Extension 72 1 min 1 
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2.6. Wax Worm Model of Infection 
The wax worm model of infection uses the larval stage of the Greater Wax Moth, 
Galleria mellonella.  This species of moth, from the Pyralidae family, is found 
across most of the world, believed to have originated in Europe, and larvae 
often feed on the nests of bees, making them an occasional pest species. Fully 
grown larvae are about 28mm in length, and are of a greyish-white colour 
(Figure 2.1).   Upon death, rapid melanisation occurs resulting in the wax worm 
appearing black (Figure 2.1).  
 
 
Figure 2.1. Wax worm model of infection.   
Galleria mellonella is a commonly used insect model of infection.  (A) Worms are typically 
a greyish-white colour and 28mm in size.  Injections are carried out in the left hindmost 
pro-leg.  (B) Pigmentation tends to occur when the worms become infected resulting in a 
characteristic colour change towards brown and eventually black.  
 
 
2.6.1.  Preparation of killed Af293 germlings for wax 
worm injection 
In order to prepare killed germlings, 2x106 conidia/ml and lower were required.  
Therefore, a high number of conidia (>1x108 conidia/ml) were incubated in 
RPMI-1640 for 8 h before centrifugation at 3000rpm.  Excess media was removed 
and the A. fumigatus was resuspended in 70% ethanol before centrifugation.  
The pellet was then washed three times in PBS, before the conidia were counted 
using the haemocytometer.  Visual observation was used to confirm conidia had 
germinated and produced germlings.  The germlings were then prepared to 
required concentrations in PBS 
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2.6.2. Injection of Wax Worms with Pseudomonas 
aeruginosa and Monitoring of Survival Rates 
PA14 was inoculated in LB broth for 24 h, before centrifuging to produce a 
bacterial pellet.  This was resuspended in PBS and the optical density was 
adjusted to 0.3, giving 1x108 cells/ml.  This was then serially diluted ten-fold in 
PBS, producing concentrations of 1x107 to 1x103 cells/ml.  This corresponds with 
10,000 to 1 bacteria per injection per worm, respectively.  These concentrations 
were injected into the wax worms in measures of 10 µl.  Two negative controls 
were set up, including a vehicle PBS control and a mock-injected control.  Five 
worms were prepared for each experimental condition. 
 
During experiments, worms were kept in the fridge until very shortly before 
injection in order to keep them moderately inactive.  Once removed from the 
fridge, they were kept in a Petri dish surrounded by ice in order to keep 
conditions cool, preventing the worms from becoming too active leading to 
increased difficulty in the injecting process.  The syringe was sterilized using 
ethanol and then washed with PBS before use.  A swab was used to wash the 
area of injection for the worms using 95% ethanol in order to prevent bacteria or 
fungi present on the wax worms body from entering the wound site.  Injections 
were carried out using a 50µl Hamilton syringe with a 26G BD Microlance.  Each 
worm was injected in the left hindmost proleg with care being taken to avoid 
causing injury or bleeding to the worm.  Live and dead worms are distinguished 
by movement of the worms, although over a longer timescale worm’s shift from 
greyish-white to black in pigmentation.   
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2.6.3. Injection of Wax Worms with Pseudomonas 
aeruginosa and Aspergillus fumigatus and Monitoring of 
Survival Rates 
PA14 was prepared as detailed in Section 2.6.1 and standardized to 2x103 
cells/ml in PBS.  8 h Af293 germlings were prepared as detailed in Section 2.6.1 
and standardised to 2x106 germlings/ml.  Bacteria and killed germlings were 
mixed in a 50:50 ratio and vortexed, giving 1x103 cells/ml PA14 and 1x106 killed 
8 h germlings/ml.  PA14 alone and 8 h Af293 germlings alone were mixed in a 
50:50 ratio with PBS to give 1x103 cells/ml PA14 and 1x106 killed 8 h 
germlings/ml.  Wax worms were injected with combinational culture and PA14, 
dead 8 h Af293 germling and PBS controls as described in 2.6.2 and monitored 
for survival. 
 
2.7. Statistics 
Statistical analysis was carried out in GraphPad Prism 4 or Excel.  One-Way 
ANOVA and the Bonferroni post-test was utilised throughout the project.  
Percentage and fold change data were subjected to a natural log transformation 
to facilitate the use of a non-parametric test.  The analysis was performed using 
one-way ANOVA.  To determine where the statistical differences were between 
the groups Dunnett post-test or Bonferroni post-test were used where 
appropriate.  On some occasions where ANOVA was not appropriate t tests were 
applied with Bonferroni corrections.  The appropriate t test and post test were 
selected after analysis of the variance by f test.  Survival curve analysis for wax 
worm survival was carried out using the inbuilt survival data analysis facility 
within GraphPad Prism 4. 
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3. Results 
3.1. Media optimisation  
3.1.1. Evaluation of various media for microbial growth 
In order to maintain consistency in the growth medium in which A. fumigatus 
and P. aeruginosa were grown, several media that supported growth of both 
species was tested.  Based on a previous report, three different types of agar 
were investigated: Luria broth (LB) agar, Roswell Park Memorial Institute-1640 
medium (RPMI-1640) agar and Sabouraud Dextrose agar (SAB) (Mowat et al., 
2010).  50μl of A. fumigatus Af293 was pipetted onto the surface of the plates 
and observed over 4 days to qualitatively monitor the levels of growth.  Single 
colonies of P. aeruginosa type strains PA01 and PA14 were plated onto the 
surface of all three agar types and how well they grew was determined based on 
the levels of subjective visual growth: light (+), medium (++) or heavy (+++).  
This subjective analysis of growth allowed for the appropriateness of media to 
be indicated.  RPMI-1640 was shown to support moderate growth of both 
organisms (Table 3.1), whereas both LB and SAB variably supported the growth 
of A. fumigatus and P. aeruginosa. Therefore, RPMI-1640 was selected for future 
investigations. 
 
Table 3.1. Qualitative level of growth observed from Aspergillus fumigatus and 
Pseudomonas aeruginosa on LB, SAB and RPMI-1640 agar plates. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
              Level of growth on agar plate 
 P. aeruginosa A. fumigatus 
LB +++ + 
SAB + +++ 
RPMI-
1640 
++ ++ 
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3.1.2. Planktonic growth of different strains of 
Pseudomonas aeruginosa 
 
In order to select suitable strains of P. aeruginosa, seven strains were tested and 
planktonic growth rates assessed.  This was to ensure variation in elastase 
production was not simply due to any given strain growing at a significantly 
higher rate than the others. Rates of exponential growth (Best Fit values) are as 
follows: 0.01657 O.D/h (PA01), 0.02038 O.D/h (PA14), 0.02409 O.D/h (PA ATTC 
27853), 0.03692 O.D/h (PA 06.72747A), 1x10-7 O.D/h (PA 06.72707B), 0.03229 
O.D/h (PA 06.72747C) and 0.01998 O.D/h (PA 06.72707A).  It was shown that all 
strains reached exponential and lag phase at a similar rate (ANOVA and the 
Bonferroni post-test p>0.05), with the exception of 06.72707B, which showed 
statistically lower growth (ANOVA and the Bonferroni post-test p<0.001) than the 
other six strains (Figure 3.1).  
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Figure 3.1. Planktonic growth rates of Pseudomonas aeruginosa in RPMI-1640 media.   
P. aeruginosa type strains 01, 14 and ATTC 27853 and clinical isolates 06.72707A, 
06.72707B, 06.72747A and 06.72747C were grown in planktonic form in RPMI-1640 for 
24 h in a round bottomed 96 well microtitre plate from an initial concentration of 1 x 106 
cells/ml at 37°C. Strains demonstrated similar rates of growth (p>0.05) with the exception 
of 06.72707B (p<0.001).  This experiment was performed once in triplicate, with points 
representing the mean.  n=1. 
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3.2. Phenotypic interactions of Pseudomonas aeruginosa 
and Aspergillus fumigatus  
In order to derive insight into the interactions between P. aeruginosa and A. 
fumigatus on a phenotypic level, standard plating assays were utilised in order 
to visually describe some basic interactions between the two organisms. 
 
3.2.1.  Phenotypic interactions between Pseudomonas 
aeruginosa and Aspergillus fumigatus  
A simple plate assay was used to show P. aeruginosa/A. fumigatus interactions 
together on RPMI-1640 agar.  P. aeruginosa (PA01 and PA14) and A. fumigatus 
(Af293) were streaked onto the same plate at the same time, with the growth 
being monitored at 24 h and images taken (Figure 3.2).  It was qualitatively 
observed that a small area of inhibition occurred where the line of P. aeruginosa 
was in close contact with, but not touching, the line of Af293.  
 
 
 
 
Figure 3.2. Phenotypic interactions between Pseudomonas aeruginosa and Aspergillus 
fumigatus on the surface RPMI-1640 agar plates.   
(A) PA01 and (B) PA14 were standardised to 1×106 cells/ml in RPMI-1640 media and 
streaked once vertically onto the surface of an RPMI-1640 agar plate using a cotton swab. 
Af293 was standardised to 5×105 conidia/ml in RPMI-1640 media and a single horizontal 
line streaked perpendicularly but not touching, the other line.  Plates were incubated at 
37°C for 24 h prior to imaging.  n=1. 
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3.2.2. Pseudomonas aeruginosa inhibition of Aspergillus 
fumigatus  
In order to further investigate inhibitory interactions between the two organisms 
in a more quantitative manner, filter paper discs impregnated with A. fumigatus 
(Af293) for 24 h, were incubated on an inoculated P. aeruginosa (PA01 and PA14) 
lawn on an RPMI-1640 agar.  After 24 h incubation, the resulting zones of 
inhibition were measured and images taken (Figure 3.3).  For PA01, the zones of 
inhibition measured around the Af293-impregnated filter discs were 12, 16 and 
10mm, giving an average of 12.67mm.  For PA14, the zones of inhibition 
measured around the Af293-impregnated filter discs were 17, 15 and 12mm, 
giving an average of 14.67mm.  These results indicated that the presence of A. 
fumigatus on RPMI-1640 agar caused inhibition of P. aeruginosa growth to a 
small extent. 
 
 
Figure 3.3. Live Aspergillus fumigatus filter disc growth on Pseudomonas aeruginosa 
lawns.   
Filter paper discs containing A. fumigatus biofilms grown for 24 h at 37⁰C  10µl of 5x105 
Af293 conidia/ml in RPMI-1640, were placed onto a lawn of 20µl of (A) PA01 at 1x106 
cells/ml in PBS or (B) PA14 at 1x106 cells/ml in PBS.  After 24 h incubation, zones of 
inhibition (including the disc itself) were measured in millimetres.  The zones of inhibition 
are circled in black.  n=1. 
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The same experimental setup was also carried out with filter discs impregnated 
with 24 h P. aeruginosa (PA01 and PA14) on a newly inoculated Af293 lawn in 
order to test the ability of P. aeruginosa to inhibit A. fumigatus growth. After 
24h, the resulting zones of inhibition were measured and images taken (Figure 
3.4).  For PA01, the zones of Af293 inhibition measured surrounding the filter 
discs were 29, 16 and 20mm, giving an average of 21.67mm.  For PA14, the 
zones of Af293 inhibition measured surrounding the filter discs were 18, 24 and 
26mm, giving an average of 22.67mm.  These results indicated the presence of 
P. aeruginosa on RPMI-1640 agar caused inhibition of A. fumigatus growth. 
 
  
 
 
Figure 3.4. Live Pseudomonas aeruginosa filter disc growth on Aspergillus fumigatus 
lawns.   
Filter paper discs containing (A) PA01 or (B) PA14 1×106 cells/ml in PBS were grown for 
24 h at 37⁰C and placed onto a lawn of 20µl of 5×105 Af293 conidia/ml in RPMI-1640.  
After 24 h incubation, zones of inhibition (including the disc itself) were measured in 
millimetres. n=1. 
 
 
 
 
 
 
64 
3.3. Quantification of the Pseudomonas aeruginosa 
virulence factor elastase in the presence and 
absence of Aspergillus fumigatus 
3.3.1. Introduction 
One possible consequence of P. aeruginosa interacting with A. fumigatus is the 
up-regulation of virulence factors leading to increased pathogenicity within the 
host (Neely et al., 1986; Xu et al., 2008).  Elastase is a key virulence factor 
secreted by Pseudomonas species, therefore, this was chosen as a surrogate 
marker for virulence up-regulation of the bacteria in response to fungi (Kuang et 
al., 2011).  Elastase was selected due to its clinical relevance (Hoge R. 2010), 
and because a biochemical assay, the Elastin Congo Red (ECR) assay, was readily 
available for quantifying its production (Caballero et al., 2001; Schaber et al., 
2004).   
Initial studies involved the standardisation of the ECR assay for its use in future 
experiments throughout this project. In addition, the ECR assay was used to 
demonstrate how interactions between P. aeruginosa and various A. fumigatus 
biofilm phases affected elastase production by P. aeruginosa. 
3.3.2. Standardisation and validation of the ECR assay 
These studies were designed to determine the optimum methodology for the ECR 
assay, which underpinned experiments carried out within this project.  Studies 
were then carried out to prove that the ECR assay was suitable for measuring 
elastase produced by P. aeruginosa. 
 
3.3.2.1. Standardisation of the ECR assay with regards to ECR 
buffer concentration and incubation time.  
Several potential methodologies for the ECR assay with regards to concentration 
of buffer and incubation time have been described (Pearson et al., 1997; 
Caballero et al., 2001; Schaber et al., 2004).  In order to determine the 
optimum conditions for the purpose of these studies, a standardisation 
experiment was carried out (Figure 3.5).  For each of the concentrations of ECR 
buffer tested (2.5, 5, 10, 20 and 40 mg/ml), an increase in absorbance (OD as 
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measured at 492nm) was recorded over time. There was an exception with 2.5 
and 5 mg/ml ECR buffer, where a small decrease was observed between 6 and 7 
h time points.  No significant difference in absorbance occurred between the 
different concentrations tested with the exception of the difference between 
2.5 mg/ml and 40 mg/ml (ANOVA and the Bonferroni post-test p<0.05).  40 
mg/ml ECR buffer consistently produced higher absorbance readings than any 
other concentration used, peaking at an OD492 of 1.06 after 7 h in comparison 
with a OD492 reading of 0.45 for 20 mg/ml ECR buffer after 7 h.   As a suitably 
high absorbance reading of 0.43 was found after 6h when using 20 mg/ml ECR 
buffer, this concentration and period of incubation was utilised for future 
experiments.
 
Figure 3.5. Standardisation of the ECR assay with regards to buffer concentration and 
incubation time.   
PA14 was grown at 1×106 cells/ml in a final volume of 500µl in RPMI-1640 media in a 24-
well plate for 1, 2, 3, 4, 5, 6 and 7 h before quantification of elastase via the ECR assay 
utilising ECR buffer concentrations of 2.5, 5, 10, 20 and 40mg/ml Elastin-Congo Red.  No 
significant difference (p>0.05) in absorbance was observed between 24 h PA14 
supernatants, with the exception of 2.5mg/ml and 40mg/ml ECR buffer.  Each experiment 
was performed in triplicate, with points representing the mean.  n=1. 
 
   
66 
3.3.2.2. Elastase Standard Curve for the ECR Assay 
Quantification of the elastase produced by P. aeruginosa was assessed using a 
standard curve of known concentrations of elastase in relation to the level of 
soluble pigment produced.  In the representative standard curve shown (Figure 
3.6), a clear correlation (R2=0.9974) was found between concentration of 
elastase and absorbance at 492nm of soluble product.  The gradient of the 
straight line resulting from this standard curve was then used to calculate the 
concentration of elastase. An elastase standard curve was set up each time the 
assay was carried out for these studies, with the assay being deemed successful 
when the R2 value of the standard curve was more than or equal to 0.95.  If the 
standard curve varied from this, this was deemed as an internal control showing 
that the assay had failed. 
 
Figure 3.6. Representative ECR standard curve.   
Presence of soluble ECR pigment increases as the concentration of elastase increases.  
Porcine pancreatic elastase was incubated in 100µl of RPMI-1640 media at various 
concentrations (0.125, 0.25, 0.5, 1, 2, 4, 8, 16, 32 µg/ml)  with 100µl of 20 mg/ml ECR 
buffer for 6 h, before the insoluble product was removed and the absorbance of the 
soluble pigment read at 492nm.  This data was taken from a single representative 
determination run in duplicate with points representing the mean.  n=1. 
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3.3.2.3. Elastase production of selected Pseudomonas 
aeruginosa strains 
The elastase production of several strains of P. aeruginosa (Chapter 2.1) was 
measured in order to determine whether the ECR assay could successfully detect 
elastolytic activity in P. aeruginosa, and also which strains were best suited for 
use within future studies.   
Elastase production was shown to vary between the strains tested (Figure 3.7).  
PA01 showed the highest level of elastase production, with 2.51µg/ml elastase 
being measured in comparison to elastase production as seen in PA14 with 2.18 
µg/ml, a 115.1% increase.   Both type strains of P. aeruginosa were shown to 
produce greater levels of elastase than mucoid and non-mucoid clinical isolates 
PA 06.72747A (M) and PA 06.72747C (NM), which produced 2.03 µg/ml and 1.79 
µg/ml, respectively.  Mucoid and non-mucoid strains PA 06.72747A (M) and 
06.72747C (NM), produced 2.03 µg/ml and 1.79 µg/ml, respectively.   Type 
strain PA ATTC 27853 was discounted from further studies as it produced 
negligible amounts of elastase (0.01 µg/ml), as was mucoid and non-mucoid 
clinical isolates PA 06.72707A (NM) and PA 06.72707B (M) as the mucoid strain 
failed to produce elastase, with a mere 0.01 µg/ml elastase being measured.  As 
mucoid and non-mucoid clinical isolates were being used for comparison studies 
within the same strain, PA 06.72707B (M) being discounted from future studies 
meant that PA 06.72707A (NM) was also discounted.   This was performed for 
strain selection and therefore was performed once as a screen. 
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Figure 3.7. Elastase production of selected strains of Pseudomonas aeruginosa. 
P. aeruginosa elastase production is variable.  Seven strains of P. aeruginosa were 
standardised to 1x106 cells/ml in RPMI-1640 media, with 500μl added to a 24-well plate 
for 24 h before quantification of elastase.  A significant difference (p<0.001) was found to 
occur between the various strains.  The bars and whisker represent the mean plus 
standard deviation of the mean.  n=1. 
 
 
3.3.2.4. Pseudomonas aeruginosa mutants deficient in elastase 
production were not detected by the ECR assay 
This study aimed to verify that the ECR assay successfully measured elastase 
production in P. aeruginosa.  Mutants with deletions in the genes controlling the 
expression of elastase (PA01 ΔLasI and PA01 ΔLasR) were selected as controls.  
PA01 ΔLasI is unable to produce homoserine lactones and PA01 ΔLasR is able to 
produce homoserine lactones but unable to respond to them.  These were 
compared against the wild type PA01 strain to show that the assay did not 
detect elastase in strains deficient in elastase production (Figure 3.8). 
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Elastase production of PA01 wild type in culture was significantly higher than 
that of PA01 ΔLasI and PA01 ΔLasR (ANOVA and the Bonferroni post-test p<0.001) 
from a mean production of 1.12 µg/ml elastase to 0.12 µg/ml elastase (89.3% 
decrease) and 0.10 µg/ml elastase (91.1% decrease), respectively.  These results 
indicated that the elastase production of PA01 in culture was considerably 
greater than that of either elastase-deficient mutant as measured by the ECR 
assay, verifying the validity of the assay. 
 
 
Figure 3.8. Elastase-deficient PA01 strains are not detected by the ECR assay.   
PA01 and two respective quorum sensing knockout mutants, ΔLasI and ΔLasR, were 
adjusted to 1x106 cells/ml in RPMI-1640. Cells were incubated for 24 h in a 24 well plate 
at 500µl per well in RPMI-1640 before elastase quantification by the ECR assay.  A 
significantly higher level of elastase (p<0.001) was observed in PA01 in comparison to 
both quorum sensing mutants.  Each experiment was carried on three separate occasions 
and performed triplicate, with bars and whisker representing the mean plus standard 
deviation of the mean. n=3. 
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3.3.3. Elastase production of bacteria in response to 24 hour 
Aspergillus fumigatus  
These studies were designed to test the hypothesis that the presence of A. 
fumigatus 24 h biofilm would lead to a change in virulence expression in P. 
aeruginosa during co-culture of the two organisms.  Moreover, a secondary 
relevant bacterial pathogen of the CF lung, Burkholderia cenocepacia, was also 
examined.  In order to test this hypothesis, a series of experiments were carried 
out in which two P. aeruginosa wild-type strains (PA01 and PA14), and one B. 
cenocepacia wild-type strain (K562), were incubated with 24 h live or dead A. 
fumigatus biofilms and the quantities of virulence factor elastase produced were 
measured. 
3.3.3.1. Elastase production by Pseudomonas aeruginosa in 
response to Aspergillus fumigatus biofilm 
Elastase production of wild-type P. aeruginosa was measured in response to both 
live and dead 24 h Af293 biofilm in comparison with untreated control, following 
24 h co-incubation.   
 
Elastase production of PA01 culture (Figure 3.9A) was significantly increased in 
the presence of dead 24 h Af293 biofilm (ANOVA and the Dunnett post-test 
p<0.001) as with PA14, increasing from a mean production of 0.77 µg/ml 
elastase to 1.77 µg/ml elastase, showing a 127.9% increase.  However, no 
significant difference was observed for PA01 in culture in the presence of live 
24h Af293 biofilm (ANOVA and the Dunnett post-test p>0.05) with the treated 
PA01 producing a mean production of 0.2 µg/ml elastase in comparison to the 
control producing 0.77 µg/ml elastase, a decrease of 74.5%.   
Elastase production of PA14 culture (Figure 3.9) was significantly increased in 
the presence of dead 24 h Af293 biofilm (ANOVA and the Dunnett post-test 
p<0.01) from a mean production of 1.03 µg/ml elastase to 1.67 µg/ml elastase, 
showing a 61% increase in comparison with the control.  In addition to this, 
elastase production of PA14 was significantly decreased in the presence of live 
24 h Af293 biofilm (ANOVA and the Dunnett post-test p<0.01) from 1.03 µg/ml 
elastase to 0.20 µg/ml elastase, an 80.54% decrease in comparison with the 
control.  These results indicated that the elastase production of PA14 in culture 
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varies due to the presence of both live and dead 24 h Af293 biofilm.  The trend 
of dead 24 h Af293 biofilm being associated with an increase in elastase is 
maintained between PA14 and PA01, whereas a decrease in elastase production 
in response to live 24h Af293 biofilm is only observed in PA14, not PA01. 
 
Figure 3.9. Elastase production of Pseudomonas aeruginosa in response to 24 hour 
Aspergillus fumigatus biofilm.   
(A) PA01 and (B) PA14 were grown at 1x106 cells/ml in a final volume of 500µl in RPMI-
1640 media in a 24-well plate in the presence of live or dead 24 h Af293 biofilm, and a 
control containing no Af293 biofilm, for 24 h before quantification of elastase.  Each 
experiment was carried on three separate occasions and performed in triplicate, with bars 
and whisker representing the mean plus standard deviation of the mean.  n=3. 
 
3.3.3.2. Elastase production of wild type Burkholderia 
cenocepacia in response to 24 hour Aspergillus fumigatus 
biofilm 
Although P. aeruginosa is the most prominent bacterium associated with CF, 
multiple other species are also associated with the disease, including B. 
cenocepacia (Govan and Deretic 1996).  In order to determine whether the 
effects of Af293 on P. aeruginosa were unique to that organism or also occurred 
in other relevant bacteria, the effect of 24 h Af293 biofilm on B. cenocepacia 
K562 was determined (Figure 3.10). 
 
Elastase production of B. cenocepacia K562 was not significantly increased in the 
presence of dead 24h Af293 biofilm (ANOVA and the Dunnett post-test p>0.05) 
unlike the P. aeruginosa strains tested, where elastase was increased from a 
mean production of 3.71 µg/ml to 5.7 µg/ml, a 53.2% increase.  A significant 
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decrease was observed for B. cenocepacia K562 in culture in the presence of live 
24h Af293 biofilm (ANOVA and the Dunnett post-test p<0.01) with the treated B. 
cenocepacia K562 producing 0.11µg/ml elastase in comparison to the control 
producing 3.71 µg/ml, a 97% decrease.  These results indicated that B. 
cenocepacia did not produce an increased level of elastase in response to dead 
24h Af293 biofilm, in contrast with both P. aeruginosa strains treated, but a 
decrease in elastase is observed in response to dead 24h Af293 biofilm as with 
PA01.  
 
 
Figure 3.10. Elastase production of Burkholderia cenocepacia K562 in response to 24 hour 
Aspergillus fumigatus biofilm.   
B. cenocepacia K562 was grown at 1x106 cells/ml in a final volume of 500µl in RPMI-1640 
media in a 24-well plate in the presence of live or dead 24 h Af293 biofilm, and a control 
containing no Af293 biofilm, for 24 h before quantification of elastase.  Each experiment 
was carried on three separate occasions and performed in triplicate, with bars and 
whisker representing the mean plus standard deviation of the mean. n=3. 
 
  
73 
3.3.3.3. Comparison of elastase production from mucoid and 
non-mucoid Pseudomonas aeruginosa in the presence and 
absence of 24 hour Aspergillus fumigatus biofilm 
 
A common phenotypic change of P. aeruginosa within the CF lung is that of the 
non-mucoid phenotype to the mucoid (Govan and Deretic 1996).  That is, the 
bacteria over-express alginate during the chronic stage of respiratory infection 
in CF which increases their pathogenic potential.  A mucoid and non-mucoid 
clinical isolate, PA 06.72747A and PA 06.72747C respectively, were tested in 
order to compare the two phenotypes in regards to elastase production in the 
presence of live and dead 24 h Af293 biofilm (Fig 3.11).   
 
Elastase production of PA 06.72747A (M) was significantly increased in the 
presence of dead 24 h Af293 biofilm (ANOVA and the Dunnett post-test p<0.05) 
from a mean production of 1.58 µg/ml elastase to 3.09 µg/ml elastase, showing 
a 95.4% increase in comparison with the control.  In addition, elastase 
production of PA 06.72747A (M) was significantly decreased in the presence of 
live Af293 biofilm (ANOVA and the Dunnett post-test p<0.05) from 1.58 µg/ml 
elastase to 0.14 µg/ml elastase, a 91.3% decrease in comparison with the 
control.  Elastase production of PA 06.72747C (NM) was significantly increased by 
the presence of dead 24 h Af293 biofilm (ANOVA and the Dunnett post-test 
p<0.001) from a mean production of 0.73 µg/ml elastase to 1.83 µg/ml elastase, 
showing a 150.5% increase in comparison with the control.  Elastase production 
of PA 06.72747C (NM) culture showed a significant decrease in the presence of 
live Af293 biofilm (ANOVA and the Dunnett post-test p<0.01) from 0.73 µg/ml 
elastase to 0.17 µg/ml elastase, a 76.7% decrease in comparison with the 
control.  These results indicated that elastase production of both mucoid and 
non-mucoid P. aeruginosa were significantly affected by the presence of both 
live and dead 24 h Af293 biofilms.  This was more significant for non-mucoid 
strains.  Due to the greater relevance of mucoid P. aeruginosa to the CF lung in 
comparison with non-mucoid P. aeruginosa, this study did not reveal a greater 
risk of increased elastase production in strains of greater clinical relevance. 
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Figure 3.11. Comparison of the elastase production of mucoid and non-mucoid 
Pseudomonas aeruginosa in the presence and absence of Aspergillus fumigatus biofilm. 
PA 06.72747A (mucoid) and PA 06.72747C (non-mucoid) were grown at 1x106 cells/ml in 
a final volume of 500µl in RPMI-1640 media in a 24-well plate in the presence of live 24 h 
Af293 biofilm or dead 24 h Af293 biofilm, and a control containing no Af293 biofilm, for 24 
h before quantification of elastase.  Each experiment was carried on three separate 
occasions and performed triplicate, with bars and whisker representing the mean plus 
standard deviation of the mean.  n=3. 
 
 
3.3.4. Effect of various stages of Aspergillus fumigatus 
biofilm growth on the elastase production of 
Pseudomonas aeruginosa 
 
A. fumigatus has multiple distinct phases of biofilm development.  Four time 
points were selected to correspond with these stages – 8 h (germlings), 12 h 
(monolayer of proliferating mycelia) and 24 h and 48 h (biofilm, with densely 
intertwined hyphae) (Rajendran et al., 2011). As it is unlikely that P. aeruginosa 
would simply encounter A. fumigatus at precisely 24 h, this study allowed for a 
broader range of A. fumigatus biofilms to be tested in order to reveal possible 
variations in P. aeruginosa elastase production in response to A. fumigatus.  
Type strains PA01 and PA14 were incubated in culture with all 4 Af293 time 
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points and a control containing no Af293 biofilm for 24 h before elastase 
quantification. 
Elastase production of PA01 culture (Figure 3.12) was significantly increased in 
the presence of dead 8 h, 12 h and 24 h Af293 biofilm (ANOVA and the Dunnett 
post-test p<0.05, p<0.01 and p<0.001, respectively).  A mean production of 0.51 
µg/ml elastase for PA01 alone rose to 1.68 µg/ml elastase in the presence of 
dead 12 h Af293, showing a 171.3% increase, and to 1.78 µg/ml elastase in the 
presence of dead 24 h Af293, showing a 246.9% increase.  Elastase production of 
PA01 in culture was not significantly affected (ANOVA and the Dunnett post-test 
p>0.05) by the presence of dead 8 h Af293 or 48 h Af293, with resulting mean 
productions of elastase of 1.38 µg/ml (171.2% increase) and 0.94 µg/ml (83.9% 
increase) respectively. 
 
Moreover, the presence of live 8, 12, 24 and 48 h live Af293 led to no significant 
difference (ANOVA and the Dunnett post-test p>0.05) in elastase production of 
PA01 in culture, resulting in mean elastase production of 0.29 µg/ml (42.2% 
decrease), 0.19 µg/ml (62.1% decrease), 0.20 µg/ml (61.1% decrease) and 0.22 
µg/ml (56.9% decrease), respectively, in comparison with the control. 
 
In contrast with that of PA01 culture, elastase production of PA14 culture was 
significantly increased in the presence of all four dead Af293 biofilm phases.  
The level of statistical significance varied over 8, 12, 24 and 48 h (ANOVA and 
the Dunnett post-test p<0.05, p<0.001, p<0.001 and p<0.05 respectively).  The 
mean production for PA14 alone was 0.63 µg/ml elastase, which rose to 1.68 
µg/ml elastase in the presence of dead 8 h Af293, (202.4% increase), to 2.48 
µg/ml elastase in the presence of dead 12 h Af293 (293.8% increase), to 2.53 
µg/ml elastase in the presence of dead 24 h Af293 (302.5% increase) and to 1.87 
µg/ml in the presence of dead 48 h Af293 (197.7% increase). 
 
The presence of live 8, 12, 24 and 48 h live Af293 had no significant difference 
(ANOVA and the Dunnett post-test p>0.05) in elastase production of PA14 in 
culture, resulting in mean elastase production of 0.16 µg/ml (74.1% decrease), 
0.36 µg/ml (42.6% decrease), 0.22 µg/ml (65.7% decrease) and 0.17 µg/ml 
(27.8%), respectively, in comparison with the control. 
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Figure 3.12. Effect of various phases of Aspergillus fumigatus biofilm growth on the 
elastase production of Pseudomonas aeruginosa.   
(A) PA01 and (B) PA14 were grown at 1x106 cells/ml in a final volume of 500µl in RPMI-
1640 media in a 24-well plate in the presence of live or dead 8 h, 12 h, 24 h or 48 h Af293 
and a control, for 24 h before quantification of elastase.  Each experiment was carried on 
three separate occasions and performed triplicate, with bars and whisker representing the 
mean plus standard deviation of the mean.  n=3.   
 
3.3.5. Effect of an inorganic substrate (latex beads) on 
elastase production by Pseudomonas aeruginosa  
A control experiment was set up using an inorganic substrate (0.8µm latex 
beads, Sigma) to test whether the presence of a physical scaffold led to an 
alteration in elastase production by P. aeruginosa.  10µl of latex beads were 
diluted two-fold to give a range of concentrations for testing.  Two strains PA01 
and PA14 were used in these experiments.  Elastase production by PA01 and 
PA14 (Figure 3.13) was not significantly affected by the presence of latex beads 
(ANOVAp>0.05).  These results indicated that the increase in elastase activity 
observed previously in response to dead Af293 biofilm was not simply due to the 
presence of a physical structure in the P. aeruginosa culture. 
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Figure 3.13. Effect of an inorganic substrate (latex beads) on elastase production by 
Pseudomonas aeruginosa.   
Both (A) PA01 and (B) PA14 were grown at 1x106 cells/ml in a final volume of 500µl of 
inRPMI-1640 media in a 24-well plate in the presence and absence of two fold dilutions of 
latex beads (starting with 1/50 dilution of beads from stock, equivalent to 10µl of latex 
beads) for 24 h before quantification of elastase.  Each experiment was carried on three 
separate occasions and performed triplicate, with bars and whisker representing the mean 
plus standard deviation of the mean.  n=3. 
 
 
3.3.6. Effect of disrupting Aspergillus fumigatus biofilm 
structure on Pseudomonas aeruginosa elastase 
production 
 
Given the conclusion that dead Af293 biofilm induces a significant increase in 
elastase production by P. aeruginosa, the question of why this occurs must be 
asked.  This study tested if the physical structure of the biofilm was responsible. 
To test this, dead 24 h Af293 biofilms were disrupted as described in Chapter 
2.1.2.3 and incubated with PA01 over 24 h (Figure 3.14).   
Elastase production of PA01 was significantly increased in the presence of intact 
dead 24 h Af293 biofilm (ANOVA and the Bonferroni post-test p<0.001) from a 
mean production of 0.23 µg/ml elastase to 0.63µg/ml elastase, showing a 177.5% 
increase in comparison with the control.  In contrast to this, elastase production 
of PA01 was not significantly affected by the presence of disrupted dead 24 h 
Af293 biofilm (ANOVA and the Bonferroni post-test p>0.05) from 0.23 µg/ml 
elastase to 0.26 µg/ml elastase, a 14.9% in comparison with the control.  These 
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results indicated that the structure of dead 24 h Af293 biofilm was essential to 
the increase in elastolytic activity observed in PA01. 
 
 
Figure 3.14. Effect of disrupting Aspergillus fumigatus biofilm structure on Pseudomonas 
aeruginosa elastase production.   
PA01 was grown at 1x106 cells/ml in a final volume of 500µl in RPMI-1640 media in a 24-
well plate in the presence of intact dead 24 h Af293 biofilm or at 2x106 cells/ml in a final 
volume of 250µl in RPMI-1640 media with disrupted dead 24h Af293 biofilm at a final 
volume of 250µl in RPMI-1640 media, and a control containing no Af293 biofilm, for 24 h 
before quantification of elastase. Each experiment was carried on three separate 
occasions and performed triplicate, with bars and whisker representing the mean plus 
standard deviation of the mean.  n=3. 
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3.4. Expression of Pseudomonas aeruginosa LasB in 
response to Aspergillus fumigatus 
3.4.1. Primer validation 
In order to validate the primers selected for this study, a serial tenfold dilution 
of cDNA extracted from PA01 was used to demonstrate that primer binding 
increased as concentration of cDNA increased (Figure 3.15). The protocol for this 
was taken from the paper in which the primers were originally described (Lee et 
al., 2011).  Primer efficiency was calculated as percentage efficiency, showing 
that rpoD (encoding for an RNA polymerase) was 96% efficient and LasB 
(encoding elastase) was 92% efficient.  Primer efficiency is regarded as 
acceptable when it falls between 90% and 110% (Taylor et al., 2010).  Therefore, 
the primers efficiently amplified cDNA, meaning they were sufficient for use in 
these studies. 
 
 
Figure 3.15. Validation of rpoD and  primers.   
Tenfold serial dilutions of PA01 cDNA (2 ng/µl, 0.2 ng/µl, 0.02 ng/µl and 0.002 ng/µl) were 
used for assessing primers for (A) rpoD and (B) LasB, in duplicate.  n=1. 
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3.4.2. Gene expression of Pseudomonas aeruginosa LasB in 
response to Aspergillus fumigatus biofilm 
Real-time PCR was carried out to assess the levels of LasB gene expression in 
PA01 in the presence and absence of dead 24 h Af293 biofilm at various time 
points (1, 4, 8 and 24 h). Gene regulation was standardised to housekeeping 
gene rpoD. Fold change in the presence of dead Af293 biofilm was determined 
individually for each time point (Figure 3.16).  Fold change of LasB expression in 
PA01 grown with dead 24 h Af293 biofilm varies as follows: at 1 h there was a 
0.45 fold decrease, at 4 h there was a 3.66 fold increase, at 8 h there was a 0.58 
fold decrease, and at 24 h there was a 0.23 fold decrease.    For statistical 
analysis, the fold change data was subjected to a natural log transformation ( 
ln(+k) ) before analysis by t test.  No significant difference (p>0.05) was found in 
gene expression of LasB relative to rpoD at any time point. 
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Figure 3.16. Pseudomonas aeruginosa LasB expression varies over time in response to 
dead 24 hour Aspergillus fumigatus biofilm.   
LasB gene regulation in PA01 cells stimulated with dead 24 h Af293 biofilm was assessed 
through real-time PCR using extracted DNA from P. aeruginosa. Fold change was 
calculated in relation to a PA01 control using rpoD as a housekeeping gene. Fold change 
for PA01 in the presence of dead Af293 at each time point is determined in relation to the 
respective expression at that time point.  Experiments were carried out a total of 3 times, 
in duplicate.  n=3. 
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3.5. Effect of Pseudomonas aeruginosa and 
Aspergillus fumigatus on a human lung cell line 
3.5.1. Effect of Pseudomonas aeruginosa and Aspergillus 
fumigatus supernatants on A549 cells 
As P. aeruginosa and A. fumigatus are known pathogens of the CF lung, this 
study sought to determine how supernatants from both organisms alone and 
from co-cultures affected an epithelial cell line taken from the human lung 
(A549) as a representation of how these species might affect the CF lung in vivo. 
 
3.5.1.1. Effect of Pseudomonas aeruginosa, Aspergillus fumigatus 
and combinational supernatants on A549 cell viability 
Supernatants were collected from the following cultures following 24 h 
incubation: PA14; live 24 h Af293 biofilm; dead 24 h Af293 biofilm; PA14 co-
cultured with live 24 h Af293 biofilm; and PA14 co-cultured with dead 24 h Af293 
biofilm.  Uncultured 0 h Af293 conidia were also used as a control.  A549 cells 
were treated with microbial supernatants for 24 h as described in Chapter 
2.4.5.1., prior to cell viability testing using alamarBlue.  For statistical analysis, 
the % reduction data was subjected to a natural log transformation (ln(+k)) 
before the following analysis: PA14 was compared with PA14 plus live Af293 and 
with PA14 with dead Af293 using one-way ANOVA and the Dunnett post test.  In 
addition comparisons were made between live and dead Af293, between live 
Af293 and live Af293 plus PA14 and between dead Af293 and dead Af293 plus 
PA14 using a the t test with a Bonferroni correction. 
 
In comparison with the media control, the % reduction of alamarBlue observed 
for the supernatants tested were as follows: PA14 (91.77% reduction); 0 h Af293 
conidia (14.3% reduction); live 24 h Af293 biofilm (11.99% reduction); dead 24 h 
Af293 biofilm (93.87% reduction); PA14 co-cultured with live 24 h Af293 biofilm 
(12.6% reduction); and PA14 co-cultured with dead 24 h Af293 biofilm (1.65% 
increase). 
 
PA14 resulted in a considerable reduction of alamarBlue by A549 cells in 
comparison with media control (ANOVA and the Dunnett post-test p<0.01).  The 
use of any supernatants containing live Af293 biofilm (0 h conidia or 24 h 
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biofilm, with or without PA14) resulted in a considerable % reduction of 
alamarBlue (ANOVA and the Dunnett post-test p<0.001), demonstrating the 
highly cytotoxic effect of live Af293 on A549 cells.  In contrast to this, 
supernatants containing dead 24 h Af293 biofilm (alone, and with PA14) showed 
no considerable reduction in % reduction of alamarBlue (ANOVA and the Dunnett 
post-test p>0.05).  No difference was found to occur in A549 cell viability 
between dead 24 h Af293 biofilm and 24 h dead Af293 biofilm co-cultured with 
PA14 (ANOVA and the Dunnett post-test p<0.05).  A highly significant difference 
occurred in A549 cell viability between live and dead 24 h Af293 with live Af293 
causing a considerable loss in cell viability (t test with Bonferonni correction, 
p<0.001). 
 
 
 
Figure 3.17. Effect of Pseudomonas aeruginosa, Aspergillus fumigatus and combinational 
supernatants on A549 cell viability.   
Supernatants taken from PA14, Af293 and co-cultures of the two species result in various 
effects on the % reduction of AlamarBlue by A549 cells.  A549 alveolar lung epithelial 
cells were cultured in 24 well tissue culture plates. Cells were stimulated with 
supernatants from the following 24 h cultures: PA14; 0 h Af293 conidia; live 24 h Af293 
biofilm; dead 24 h Af293 biofilm; PA14 co-cultured with live 24 h Af293 biofilm; and PA14 
co-cultured with dead 24 h Af293 biofilm. Percentage reduction of alamarBlue was 
calculated relative to a media only control.  Each experiment was carried on three 
separate occasions and performed in triplicate, with bars and whiskers representing the 
mean plus standard deviation of the mean.  n=3. 
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3.5.1.2.   Light microscopy of the effect of Pseudomonas 
aeruginosa, Aspergillus fumigatus and combinational 
supernatants on A549 cells 
Light microscopy was utilised to examine how the morphology of A549 cells 
varied after treatment with P. aeruginosa, 0 h conidia, both live and dead 24 h 
A. fumigatus, and combinational supernatants in comparison with an untreated 
control (Figure 3.18). 
 
In the untreated control, A549 cells remain adherent to the plastic surface of 
the well.  Most cells show a shape characteristic of A549 cells (as shown) 
although some showed a more rounded circular morphology.  Treatment with 
PA14 alone resulted in a mixture of adherent cells, rounded cells and rounded 
cells which had detached from the plastic surface.  When supernatants taken 
from PA14 co-cultured with dead 24 h Af293 biofilm (which had been shown to 
cause little difference to the morphology of cells in comparison with the 
control), fewer adherent cells were noted in comparison with supernatants 
taken from PA14 culture alone, with almost all cells being detached and 
rounded.  Supernatants from cultures containing live Af293 (0 h Af293, live 24 h 
Af293 biofilm and PA14 co-cultured with live 24 h Af293 biofilm) all displayed 
clear cell blebbing and cell damage (Fackler and Grosse 2008), demonstrating 
that live Af293 had a strong negative effect on cell morphology. 
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Figure 3.18. Light microscopy of the effect of supernatants from Pseudomonas aeruginosa, 
Aspergillus fumigatus, and combinational co-cultures on the A549 cell line.   
Light microscopy of a field within the well of a 24-well plate containing A549 cells treated 
with different supernatants at ×25 magnification.  Supernatants tested were taken from 24 
h cultures of: (A) RPMI-1640 control; (B) PA14; (C) 0 h Af293 conidia; (D) dead Af293 
biofilm; (E) live Af293 biofilm; (F) PA14 incubated with dead 24 h Af293; (G) PA14 
incubated with live Af293 biofilm for 24 h.  Each photograph is taken from one 
representative experiment.  n=1. 
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3.5.2. Effect of elastase on the A549 cell line 
Previous studies used the surrogate virulence factor elastase from P. aeruginosa 
as an indicator of virulence alterations in P. aeruginosa due to the presence of 
A. fumigatus.  By demonstrating whether or not elastase had a notable effect on 
A549 lung cells, both in regards to cell viability and morphology, this study 
aimed to establish the effect of the surrogate virulence factor on cells relevant 
to respiratory disease. 
 
3.5.2.1. Effect of elastase on A549 cell viability 
This study aimed to examine how elastase affected A549 cell viability, as 
measured by the alamarBlue assay.  Several concentrations of elastase (0.5, 4, 
16 and 128 µg/ml) were incubated with A549 cells for 24 h before cell viability 
was measured (Figure 3.19).  For statistical analysis, the % reduction data was 
subjected to a natural log transformation (ln(+k)) before analysis by one-way 
ANOVA and the Bonferroni post-test.  No significant difference (ANOVA and the 
Bonferroni post-test p>0.05) was found with concentrations of elastase. 
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Figure 3.19. Effect of elastase on A549 cell viability.   
A549 alveolar lung epithelial cells were cultured in 24 well tissue culture plates for 24 h at 
37⁰C in 5% CO2/ air atmosphere. Cells were stimulated with various concentrations of 
elastase (0.5, 4, 16, 128µg/ml), in relation to a media control.  Following 24 h incubation, 
alamarBlue was added and absorbance readings were taken after 3 h incubation.  Each 
experiment was carried on three separate occasions and performed triplicate, with bars 
and whisker representing the mean plus standard deviation of the mean.  n=3. 
 
 
3.5.2.2. Light Microscopy of effect of elastase on A549 cells 
Light microscopy was utilised to examine how the appearance of A549 cells 
varied after treatment (Figure 3.20) in comparison with a media control.  It was 
shown that little difference was found at concentrations as high as 16 µg/ml, 
with cell morphology remaining very similar to that of the media control, with 
the exception of 4 µg/ml elastase treatment in which some cell rounding was 
noted.  However, at 128 µg/ml the vast majority of A549 cells became rounded 
and detached from the plastic surface of the 24-well plate.  
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Figure 3.20. Effect of elastase on A549 cell morphology.   
Light microscopy of a field within the well of a 24-well plate containing A549 cells treated 
with different concentrations of pancreatic porcine elastase at ×25 magnification. The 
concentrations tested were: (A) RPMI-1640 control; (B) 0.5 µg/ml elastase; (C) 4 µg/ml 
elastase; (D) 16 µg/ml elastase; (E) 128 µg/ml elastase.  Each photograph is taken from 
one representative experiment.  n=1. 
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3.6. Wax Worm Model of Pseudomonas and 
Aspergillus co-infection 
3.6.1. Survival rates of Galleria mellonella injected with 
various concentrations of P. aeruginosa 
 
These studies aimed to establish the killing effect of various concentrations of P. 
aeruginosa type strain PA14 on G. mellonella wax worms.  This was to establish 
if a dose dependent response existed, and if so which concentration resulted in 
mortality of the wax worms at a rate allowing for an increase in virulence when 
co-incubated with dead Af293 germlings to be observable due to a comparative 
decrease in survival rates (Figure 3.21). 
 
It was shown that there was a significant difference (Logrank test p<0.001) 
between the survival rates of worms injected with PA14 of various 
concentrations.  The median survival for injected worms was as follows: 1×105 
cells/ml (12 h); 1×104 and 1×103 cells/ml (18 h); 1×102 cells/ml (24 h); and 1×101 
cells/ml (42 h).  18 h was decided as the optimum median survival rate, and 
1×103 cells/ml was decided on as, despite the median remaining the same, more 
worms died at an earlier rate for 1×104 cells/ml. 
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Figure 3.21. Survival rates of Galleria mellonella injected with various concentrations of 
Pseudomonas aeruginosa.   
Wax worm larvae were inoculated with 10µl of serial dilutions (105, 104, 103, 102 and 101 
cells/ml) of strain PA14 suspended in PBS, as well as a PBS control.  Survival was 
monitored for 48 h. A dose-dependent response was found.  Kaplan-Meier survival curves 
were determined for three independent experiments each using five worms per condition.  
n=3.   
 
3.6.2. Survival rates of G. mellonella injected with 
killed A. fumigatus germlings 
 
The aim of this experiment was to demonstrate that dead A. fumigatus caused 
no significant effect on the survival of wax worms.  This would therefore mean 
that if a combination of dead A. fumigatus and live P. aeruginosa led to a 
significantly faster death rate than P. aeruginosa alone it could be inferred that 
this was due to P. aeruginosa becoming more virulent.  Wax worms were 
injected with various concentrations of ethanol killed germlings and monitored 
for survival (Figure 3.22). 
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As no significant difference in survival rates was found between the different 
concentrations of dead Af293 8 h germlings used (Logrank test p>0.05), and very 
few worms died, it was decided that the highest concentration (1x106 cells/ml) 
should be used for combinational studies to increase the exposure of P. 
aeruginosa to Af293. 
 
Figure 3.22. Survival curves of killed Aspergillus fumigatus germlings in the Galleria 
mellonella infection model.   
Wax worm larvae were inoculated with 10µl of serial dilutions (106, 105, 104, 103, 102 and 
101 germlings/ml) killed Af293 germlings suspended in PBS, as well as a suitable control.  
Survival was monitored for 48 h. There was no significant difference (p>0.05) in dose 
response.  Kaplan-Meier survival curves were determined for three independent 
experiments each using five worms per condition.  n=3. 
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3.6.3. Survival rates of G. mellonella injected with P. 
aeruginosa in combination with killed A. fumigatus 
germlings 
To determine if the presence of dead Af293 contributed to PA14 causing death 
at a more rapid rate in comparison with PA14 alone, PA14 was combined with 
dead 8 h Af293 germlings in PBS before injection into the worms.  Survival was 
then against suitable controls: PA14 alone, dead 8 h Af293 germlings alone and 
PBS alone (Figure 3.26). 
Although both PA14 alone and PA14 with dead Af293 germlings were significantly 
(Logrank test p<0.001) different than that of dead Af293 germlings alone, the 
median survival time for both was the same (18 h).  It was shown that PA14 
combined with dead Af293 germlings often caused greater morbidity than PA14 
alone at most individual time points.  For example, at 20 h 33% of wax worms 
injected with PA14 were still alive in comparison with 20% of wax worms 
injected with PA14 combined with dead Af293 germlings.   
The pigmentation of worms, a sign of disease, also varied between the two 
conditions (Figure 3.23).  For example, during one of the three repeats, although 
all worms were still alive 14 h post-injection, 4 worms demonstrated 
pigmentation when injected with a combination of PA14 and dead Af293 
germlings in comparison to those injected with PA14 alone, of which only 1 
worm showed signs of pigmentation (Figure 3.28).  This could hint towards the 
dead Af293 germlings having some effect on the PA14, but it is inconclusive and 
the survival rate data shows no clear effect (Logrank Test p>0.05).  It was shown 
that the median time for onset of pigmentation in worms was 14 h for worms 
injected with combinations of PA14 and dead germlings in comparison with 16 h 
for PA14 alone.  This was not shown to be a significant trend however using 
curve comparison. 
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Figure 3.23. Effect of killed Aspergillus fumigatus germlings on Pseudomonas aeruginosa 
virulence in the Galleria mellonella infection model.   
Wax worm larvae were inoculated with 10µl of PA14 at 1x103 cells/ml, killed 8 h Af293 
germlings at 1x106 germlings/ml and a co-incubation of 1x103 cells/ml PA14 with 1x106 
killed germlings/ml Af293.  Survival was monitored for 24 h. Kaplan-Meier survival curves 
were determined for three independent experiments each using five worms per condition 
and showed a dose-dependent response.  n=3.  
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Figure 3.24. Effect of killed Aspergillus fumigatus germlings combined with Pseudomonas 
aeruginosa on pigmentation the Galleria mellonella infection model.   
Wax worm larvae were inoculated with 10µl of PA14 at 1x103 cells/ml, killed Af293 8 h 
germlings at 1x106 germlings/ml and a co-incubation of 1x103 cells/ml PA14 with 1x106 
killed germlings/ml Af293.  Pigmentation was monitored for 24 h. Kaplan-Meier survival 
curves were determined for three independent experiments each using five worms per 
condition and showed a dose-dependent response.  n=3. 
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Figure 3.25. Increased pigmentation of wax worms 14 hours post-injection with 
Pseudomonas aeruginosa when combined with dead Aspergillus fumigatus germlings. 
Photographs of wax worms injected with (A) PA14 at 1x103 cells/ml and (B) PA14 at 1x103 
cells/ml combined with dead Af293 germlings at 1x106 germlings/ml in PBS 14 h post-
injection.   
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4. Discussion 
Cystic Fibrosis (CF) is the most common lethal genetic disorder within the 
Caucasian population and leaves those affected vulnerable to chronic infection 
of the respiratory tract from a variety of microbial species, with Pseudomonas 
aeruginosa and Aspergillus fumigatus serving, respectively, as important 
bacterial and fungal species implicated (Rajan and Saiman 2002; Bakare et al., 
2003; Davies et al., 2007).  It has been shown that co-infection from both 
species within the same host occurs regularly, meaning that bacterial fungal 
interactions readily occur in vivo. How these organisms interact with one 
another may result in phenotypes that have detrimental effects on the host. 
Therefore, improving our understanding of how prokaryotes interact with 
eukaryotes within the context of the CF lung may help provide insight into 
improving clinical management (Leclair and Hogan 2010; Mowat et al., 2010; 
Peleg et al., 2010).   
 
It had previously been shown that P. aeruginosa can inhibit the growth of A. 
fumigatus.  Environmental strains of Pseudomonas in the soil were shown to 
antagonistically inhibit A. flavus up to 100-fold from samples taken from a 
Mississippi cornfield (Palumbo et al., 2010).  The inhibition of A. fumigatus by 
Pseudomonas has also been described in an investigation in which a strain of P. 
fluorescens isolated from cassava starch and flour was observed to cause 
moderate inhibition of the fungus in vitro using a plate streaking method (Osha 
2005).  In the context of the species interacting in CF patients, this inhibition 
possibly occurs through action of small secreted heat-stable molecules (e.g. 
decanol), pyocyanin and 1-hydroxyphenazine (Kerr et al., 1999; Mowat et al., 
2010).  This was demonstrated by showing that both filtered and heat-killed 
supernatants from P. aeruginosa caused the same inhibitory effect in A. 
fumigatus as untreated P. aeruginosa supernatants.  A well plate assay by Kerr 
and co-workers in 1999 in which pyocyanin and 1-hydroxyphenazine were added 
to BHI agar in plastic wells containing fungal indicator strains at a 35mm radius 
showed that pyocyanin caused inhibition in both C. albicans and A. fumigatus.  
However, whilst dose-dependent inhibition of A. fumigatus occurred at higher 
levels (>19 μg/well) than in C. albicans (35 μg/well), complete inhibition of A. 
fumigatus growth was seen in comparison with partial inhibition of C. albicans.   
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The investigation by Ramage and colleagues in 2010 demonstrated a similar 
effect by showing that live P. aeruginosa incubated with live A. fumigatus 
conidia led to a significantly reduced fungal biomass (14.5%)(Mowat et al., 
2010).  Despite this, P. aeruginosa was not shown to inhibit pre-formed A. 
fumigatus biofilm. This also correlates with the work of Ramage’s group which 
showed an insignificant reduction in fungal biomass when P. aeruginosa cells 
were incubated with mature A. fumigatus biofilm (84.8% of control).  The P. 
aeruginosa quorum sensing molecules decanol, decanoic acid and dodecanol 
were solubilized and used to treat both A. fumigatus conidia and mature biofilm 
at a variety of concentrations.  These were implicated in inhibition of A. 
fumigatus by causing inhibition of fungal biomass (up to 80%) or disruption of 
fungal biofilm (up to 85%). To confirm this effect, a simple experiment was set 
up on RPMI-1640 agar plates.  Filter discs impregnated with P. aeruginosa led to 
inhibition when grown on an A. fumigatus lawn, whereas A. fumigatus discs did 
not cause inhibition on a lawn of P. aeruginosa under the same conditions.  This 
inhibition has previously been shown in C. albicans by growing a known 
antifungal strain of P. aeruginosa on a blood agar plate for 18-24 h aerobically 
before removal and chloroform killing of bacteria, and then demonstrating that 
C. albicans inoculated on this plate did not grow.  The P. aeruginosa virulence 
factor pyocyanin was shown to cause a zone of inhibition in C. albicans growth in 
a well plate assay (Kerr 1999).  This was the rationale for using pre-formed A. 
fumigatus biofilms (8, 12, 24 and 48 h biofilms) as opposed to co-incubating P. 
aeruginosa with uncultured 0 h A. fumigatus conidia.   
 
With this in mind, the main aim of these studies was to determine whether the 
interactions between P. aeruginosa and pre-formed A. fumigatus biofilm led to 
an increased risk of morbidity and mortality in the host, with a surrogate P. 
aeruginosa virulence marker being selected as an in vitro method of detection. 
P. aeruginosa possesses a vast array of potent virulence factors for potential 
selection during these studies, including pyocyanin and phospholipase C (Cox 
1986; Korbsrisate et al., 2007).  Elastase was selected as a suitable marker of P. 
aeruginosa virulence due to it being a well-documented and commonly 
expressed virulence factor, produced in over 75% of P. aeruginosa strains, and 
having a known pathogenic effect due to its cleavage of host elastin causing 
degradation of the lung structure (Kon et al., 1999; Kuang et al., 2011).  The 
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availability of a developed biochemical assay which could be used to quantify 
the amounts of elastase produced efficiently (in micrograms per millilitre) and 
as it was a well-documented cause of morbidity in the host made it a suitable 
choice for these investigations (Kothary et al., 1984; Caballero et al., 2001; 
Hoge R. 2010). 
 
The ECR assay was optimised for the in vitro quantification of elastase produced 
by P. aeruginosa in the presence of A. fumigatus biofilms.  The main 
consideration for this assay on a practical level was avoiding ECR powder being 
pipetted from samples into the plate used for optical density readings, as this 
led to false positives at early stages of the project.  A standard curve using 
known quantities of elastase was also run for each ECR plate during the study in 
order to more accurately quantify the levels of elastase present in the 
supernatants tested (Kothary et al., 1984).  In order to demonstrate that any 
changes in elastase produced by P. aeruginosa was not simply due to the 
presence of any physical contact; inorganic latex beads were selected as a 
control.  It was shown that P. aeruginosa elastase production was not 
significantly different in the presence of an inorganic substrate.  Results were 
standardised against any elastolytic activity occurring in an A. fumigatus only 
control, as it is known that A. fumigatus too can cause elastolytic activity 
(Kothary et al., 1984; Rhodes et al., 1988).   For example, of 75 A. fumigatus 
strains screened for elastase by Kothary et al. in 1984, in liquid and solid 
medium containing elastin, 71 strains were shown to produce elastase in solid 
agar, and 33 demonstrated elastase production in liquid media (Kothary et al., 
1984).  Moreover, Rhodes displayed via the use of Rose Bengal-elastin agar 
plates that all strains of A. fumigatus isolated from a sample of patients 
suffering from invasive aspergilliosis produced elastase.  This ensured that only 
P. aeruginosa elastase was taken into account.   
 
It is known that fungal biofilms can lead to the up-regulation of virulence factors 
in P. aeruginosa, as it has been shown, for example, that Candida albicans can 
stimulate phenazine production in dual-species biofilms (Cugini et al., 2010).  
This was demonstrated by inoculating P. aeruginosa strain PA14 onto C. albicans 
(strain SC5314) lawns grown on agar plates and showing that observable zones of 
red pigmentation (indicative of phenazine) occurred due to this in comparison to 
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no red pigmentation being found for both species alone.  Therefore, this served 
as a basis for testing if A. fumigatus exerted a similar effect on P. aeruginosa.  
Indeed, it was shown that the presence of dead A. fumigatus biofilm often 
resulted in a significantly higher level of elastase produced by P. aeruginosa, 
and this pattern was repeated over several strains (PA01, PA14, both clinical 
mucoid and non-mucoid strains PA 06.72747A and PA 06.72747AC) to varying 
degrees, and also within another key CF bacterial pathogen Burkholderia 
cenocepacia K56-2 (Drevinek and Mahenthiralingam 2010).  One theory as to why 
the level of elastase increased in the presence of dead A. fumigatus biofilm is 
that the P. aeruginosa bacteria scavenge nutrients from the dead fungal biofilm, 
allowing for improved growth conditions in comparison to P. aeruginosa in media 
alone (Hogan. 2009).  It is also possible that P. aeruginosa up-regulates LasB, the 
gene encoding for elastase, in response to encountering A. fumigatus (Rust et 
al., 1996).   
 
It was also shown that disruption of the dead A. fumigatus biofilm structure did 
not result in a significant increase in elastase, whereas the undisturbed dead 
biofilm caused a significant increase in elastase production by P. aeruginosa.  It 
is possible that a specific interaction between P. aeruginosa and the fungal 
biofilm structure is essential to the mechanism resulting in enhanced elastase 
production.  It is also possible that a factor released by A. fumigatus during the 
bead beating process into the supernatants, which would be contained within 
the fungal cells in the undisturbed biofilm, could counter-act the mechanism 
usually allowing P. aeruginosa to produce more elastase.  Further work is 
required to discover the exact mechanism by which P. aeruginosa shows 
increased elastolytic activity in the presence of dead A. fumigatus biofilm, and 
why the structural integrity of the dead fungal biofilm appears to be key to this 
interaction.  As an increase in elastase had not been observed when P. 
aeruginosa was exposed to live A. fumigatus biofilm, it was decided not to use a 
disrupted live biofilm in this study.  However, this could be carried out in future 
work in order to explore in more detail the interaction between A. fumigatus 
biofilm and P. aeruginosa and its virulence factors. 
 
Gene expression results for PA01 LasB, the gene, which encodes for elastase in 
P. aeruginosa, did not show a significant difference between PA01 alone and 
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PA01 grown with dead 24 h A. fumigatus biofilm at multiple time points post-
exposure (1, 4, 8 and 24 h).  This was in relation to the housekeeping gene rpoD, 
a sigma factor which has been indicated as a useful housekeeping gene within 
the literature (Potvin et al., 2008). The lack of gene expression data to 
corroborate an increase in LasB activity could perhaps imply that another 
genetic pathway is utilised to cause the increase in elastolytic activity.  The 
experiment should perhaps be repeated with a more robust housekeeping gene 
system.  For example, the use of rpoD and proC (which encodes pyrroline-5-
carboxylate reductase) simultaneously for housekeeping genes within qPCR 
studies has been recommended (Savli et al., 2003).  It is not necessary that 
elastase mRNA levels and elastase protein levels correlate, an increase in 
elastase mRNA may not be required to result in increased elastase activity.  
There could be increased transcription with increased translation matched by 
increased degradation of translated mRNA and no apparent change in mRNA 
levels when assessed by qPCR. It could simply be an increased efficiency in 
elastase mRNA translation into elastase, more efficient intracellular processing 
of elastase and secretion of elastase in P. aeruginosa given the right stimulus. 
Regardless, the in vitro ECR data did show a clear correlation between dead A. 
fumigatus and increased elastolytic activity in P. aeruginosa.  This served as a 
basis for further investigation into how combining the two species impacted 
upon the health of the host, through cell culture studies and also within an 
insect model of disease. 
 
In order to further demonstrate the validity of selecting elastase as the virulence 
factor of interest, the effect of various concentrations of elastase on a human 
lung epithelial cell line (A549) was analysed in terms of cell viability, using the 
Alamar Blue assay, and on morphological changes as seen by light microscopy 
(Lieber et al., 1976; O'Brien et al., 2000).  It has been reported that elastase 
leads to a marked decrease in A549 cell viability as determined by the MTT assay 
(Nakajoh et al., 2003).  It was shown using the Alamar Blue assay in this study, 
however, that elastase did not lead to a loss in cell viability as expected.  In 
fact, it was found to cause no significant difference in cell viability between 
concentrations of 0.5 and 16µg/ml of elastase, and a significant increase in cell 
viability by 128µg/ml.  This surprising result could be explained through 
morphological evaluation of A549 cells, which appeared to be detached from the 
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plastic surface of the 24-well plate. Therefore, through nuisances in the 
experimental design, the data presented herein provided conflicting data sets, 
i.e. detached cells were either washed out of the cell, as described by Nakojah 
and colleagues (2003), or they were left within the wells prior to metabolic 
quantification. 
 
The ability of elastase to cleave elastin resulting in A549 cell detachment has 
been previously detailed within the literature (Van Wetering et al., 1997).  The 
cleaving of elastin, leading to respiratory cells being removed from the surface 
of the respiratory tract, would naturally lead to host damage (Bruce et al., 
1985).  The discrepancy between the data collected in this study and that of 
Nakajoh et al.’s work from 2003 could be due to multiple factors, including the 
use of the MTT assay over Alamar Blue.  Alamar Blue is an assay which does not 
require killing the cells in order to measure viability in comparison with MTT, 
and it has been shown previously that Alamar Blue is generally slightly more 
sensitive than MTT (O'Brien et al., 2000; Hamid et al., 2004).  In order to further 
validate the effect of elastase on A549 cell viability, the lactate dehydrogenase 
(LDH) and neutral red assays could be utilised as alternative methodologies 
(Fotakis and Timbrell 2006).  The neutral red assay indicates the number of 
living cells in culture as neutral red dye accumulates in the cytoplasm of living 
cells with absorbance being directly proportional to the number of living cells 
(Repetto et al., 2008). The LDH assay, however, allows for a more direct 
measure of cell damage and death.  As leakage of cellular enzymes such as LDH 
are known to occur during cell damage, and LDH catalyses the conversion of 
lactate and NADH to pyruvate and NAD, respectively. this reaction then 
stimulates conversion of iodotetrazolium by diaphorase to form a formazan dye 
which can measured by an increase in fluorescence (Arechabala et al., 1999). 
    
The effect of supernatants collected from P. aeruginosa, A. fumigatus and 
combinational cultures of the two was gauged by treating A549 cells for 24 h 
before measuring cell viability via the Alamar Blue assay.  One problem which 
arose from this approach was Aspergillus was so cytotoxic that the presence of 
live Af293 supernatants alone caused such a loss in cell viability that 
combinational studies were difficult to extract meaningful data.  The 
cytotoxicity of A. fumigatus has been established in other cell lines such as 
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macrophages (Kamei et al., 2002).  An investigation into the cytotoxicity of 
clinical samples of Aspergillus isolated from hospitals utilising the MTT assay 
showed that 84% of tested strains were cytotoxic, and high cytotoxicity was 
demonstrated particularly in A. fumigatus (Gniadek et al., 2011).  A highly 
significant difference was found to occur between PA14 grown alone and PA14 
grown with dead Af293, however.  Interestingly, this showed that PA14 grown 
alone caused significantly more loss in viability of A549 cells in comparison with 
PA14 grown with dead Af293.  This fits with the data from the cell viability assay 
carried out using varying concentrations of elastase.  In that study, high levels of 
elastase increased cell detachment from the plate surface and also led to an 
increase in Alamar Blue reduction, as is the case for P. aeruginosa grown with 
dead fungal biofilm.  Light microscopy of A549 cells treated with supernatants 
from PA14 alone and PA14 grown with dead A. fumigatus biofilm did show 
increased cell rounding, and detachment for PA14 grown with dead A. fumigatus 
biofilm supernatants, in comparison to PA14 alone.  This potentially indicates 
increased elastolytic activity.  As illuminating as in vitro experimental data can 
be, the full picture of how these interactions occur in nature requires a less 
simplistic model of infection, and this is where an in vivo model of infection 
becomes pertinent.  
 
In order to analyse the effect of these interactions on a host system, the insect 
model Galleria mellonella was selected (Cotter et al., 2000).  There are 
numerous advantages to focussing on an insect model in favour of a mammalian 
system.  The correlation between the immunity of insects and the immunity of 
mammals, as well as the high probability of conserved virulence mechanisms 
from pathogens across multiple host systems means that the insect model is 
indeed suitable for early experimental trials (Tan 2002).  Moreover, they are 
easier to maintain in terms of living conditions and nutrition, and they allow the 
more complicated ethical issues of mammalian models to be avoided.  Insect 
models also allow for higher throughput in terms of organisms tested and time 
taken for survival to be gauged.  The costs are also kept low with these systems, 
and they are easier to handle (Scully and Bidochka 2006).  It has been shown 
that pathogenicity of A. fumigatus in G. mellonella matches that of A. 
fumigatus in a mice model (Slater et al., 2011). 
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A working model of how combinational infections with bacteria and fungi 
affected the survival of a host species existed within the literature (Figure 4.1) 
and was used as the basis of the wax worm studies within this project (Peleg et 
al., 2010).  Within this model, if the percentage survival for both species 
combined in a co-infection is equal to the survival rate of both species 
individually, it is considered an additive effect where both species could 
potentially be acting independently to cause host damage without any impact 
upon one another).  If the host survival rate is lower than that of both species 
individually combined, then this implies a synergistic interaction in which one or 
both species cause an increase in virulence in the other, or one species creates 
conditions which the other exploits to cause increased host damage.  If the host 
survival rate is higher than that of both species individually combined, then this 
could imply an antagonistic interaction in which one species removes the 
pathogenic effect of the other, or the host response to both species being there 
is stronger than for one species alone.   
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Figure 4.1. Theoretical survival curves for polymicrobial infections in an animal model. 
Due to the complexity of bacterial-fungal interactions within a host, it is useful for a basic 
working model of how these interactions could impact upon the survival of the host, which 
can be applied to multiple experiments within this field.  The percentage survival of the 
host species population is mapped against time (h).  Arrows pointing upwards represent 
synergy in co-infections, and arrows pointing downwards represent antagonism in co-
infections.  Although these interactions are very complex, this basic diagram allows for a 
more unified interpretation of bacterial fungal interactions in host systems and how these 
relate to host survival (Peleg et al., 2010).   
 
 
In contrast to this model, it was decided that killed 8 h A. fumigatus germlings 
would be combined with live P. aeruginosa as the results from the ECR assay had 
demonstrated that dead Aspergillus caused an increase in virulence in 
Pseudomonas.  Moreover, the dead 8 h Af293 germlings had been shown to cause 
no significant impact on the survival rates of the worms.  Therefore, the theory 
was that worms injected with PA14 combined with dead Af293 germlings would 
demonstrate a faster rate of killing in the worms in comparison to PA14 alone.   
The results from this study did not show a significant difference in survival rates 
of worms when PA14 was combined with killed germlings, however.  
Pigmentation rates of the worms was noted to be somewhat faster in those 
injected with both, but again this was not shown to be significantly different.  
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This could simply mean that although virulence is shown to increase in vitro, it 
did not do so in vivo within the conditions used.  This could perhaps be due to 
the amount of PA14 being injected being below the necessary level for an 
increase in virulence.  One possible explanation for this is that quorum sensing is 
required for the increased elastase production in P. aeruginosa exposed to dead 
Af293, and approximately one bacterium per injection is not a sufficient 
population density for this to occur (Rumbaugh et al., 2000; Erickson et al., 
2002).  It is also possible that there was an increase in the level of elastase 
produced, but given the lower population size it was not enough to manifest in a 
subsequent increase in morbidity.  For example, no significant effect occurred in 
the A549 cell culture model until 128µg/ml.  It is also possible, given the 
subjective nature of measuring infection in the wax worms, that there are 
changes within survival rates and morbidity in the worms, which are too subtle 
to be noticed within this experimental set-up.  Focussing exclusively on PA01 
may not have been the optimum approach for this study also, and other strains 
(e.g. PA14, PA 06.72747A) could have been utilised instead, including screening 
a panel of clinical isolates. 
 
In terms of future work, it would be useful to determine the exact mechanism by 
which P. aeruginosa elastolytic activity increases in the presence of dead A. 
fumigatus biofilm, and likewise the mechanism by which it decreases in the 
presence of live A. fumigatus biofilm.  A transposon mutant library could be 
utilised to this effect by using knockout mutants to determine which genes are 
essential to the mechanism.  For example, work with quorum sensing knockout 
mutants (ΔLasI and ΔLasR) already showed that the elastolytic activity was 
dependent on that quorum sensing pathway.  Moreover, all work was carried out 
using the same strain of A. fumigatus, Af293, so the use of A. fumigatus mutant 
or clinical strains could also potentially reveal which genes within A. fumigatus 
are key to its effect on P. aeruginosa (both for live and dead Aspergillus 
biofilm).  On a larger scale, using more bacterial species to test how universal 
this effect is could be useful, such as further B. cenocepacia strains, and other 
important CF pathogens such as Staphylococcus aureus and Stenotrophomonas 
maltophilia (Demko et al., 1998; Goodrich et al., 2009).   
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The wax worm model of infection could also be utilised with other strains of P. 
aeruginosa, or P. aeruginosa treated with A. fumigatus under other conditions 
e.g. P. aeruginosa grown with 24 h Af293 biofilm.  The combinational effect of 
the two pathogens could also be examined by this method as per Figure 4.1, but 
finding an effective dosage for both species, which does not lead to rapid death 
could be problematic.  Injecting the wax worms directly with elastase at various 
concentrations to establish it as a cause of death in the worms could also be a 
useful control.  Monitoring the survival of worms more frequently could also be 
valuable. 
 
Using alternative virulence factors to examine the effect of A. fumigatus on P. 
aeruginosa virulence could also be of interest, for example utilising a spot test 
on egg yolk agar in order to assay phospholipase C in P. aeruginosa from various 
conditions (Price et al., 1982).  A more ambitious approach towards exploring 
the adaptation of bacteria to A. fumigatus would be to use RNA microarrays or 
RNA-Seq to screen for gene regulation across the entire P. aeruginosa genome 
with a transcriptome approach, to detect which genes are affected and translate 
this into potential explanations for the increase in elastolytic activity (Palma et 
al., 2003; Chang et al., 2005; Waite et al., 2005).  RNA-Seq has been shown to 
be more sensitive, reproducible and to have a more dynamic range than 
microarrays, but it has also been suggested that there is an advantage to 
utilising both methods in a complimentary fashion (Kogenaru et al., 2012).  
 
Overall, this study hints at intriguing interactions between P. aeruginosa and A. 
fumigatus, with a surrogate virulence factor showing that bacterial fungal 
interactions can exert a clear influence on the activity of a bacterial virulence 
factor in a synergistic fashion.  However, given the complexities of the CF lung 
ecology, in which multiple bacterial and fungal species, all of which can be 
present in multiple strains, come into contact with each another and express 
multiple virulence factors and behaviours as a result, much work remains to be 
done in order to utilise this knowledge.  The ability to identify the mechanisms 
by which P. aeruginosa increases its virulence expression in response to A. 
fumigatus leaves us better enabled to interfere with this interaction through use 
of drugs and medication, and confer health benefits towards the CF patients still 
affected by these interactions.   
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In conclusion, the main findings of this investigation were as follows: 
 
I. P. aeruginosa elastase production is significantly increased within select 
strains in response to the presence of dead A. fumigatus biofilm.  The 
structure of the fungal biofilm is key to this increase in elastase 
production. 
II. P. aeruginosa elastase production is significantly decreased within select 
strains in response to the presence of live A. fumigatus biofilm. 
III. B. cenocepacia elastase production is significantly decreased within the 
K56-2 strain in response to the presence of live A. fumigatus biofilm. 
IV. An inorganic substrate (in this case latex beads) does not cause an 
increase in elastase production, demonstrating that the presence of any 
physical scaffold in culture does not cause P. aeruginosa elastase 
production. 
V. A qPCR approach did not demonstrate a significant increase in LasB (which 
encodes for elastase) expression in PA01 treated with various stages of A. 
fumigatus biofilm. 
VI. Elastase causes the detachment of A549 cells from plastic surfaces in 
vitro but does not cause cytotoxicity as measured by the Alamar Blue 
assay. 
VII. A significant decrease in survival time was not noted in a G. mellonella 
model of infection when P. aeruginosa was co-incubated with dead A. 
fumigatus germlings. 
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